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A B S T R A C T
Background
Pain is prevalent during orthodontics, particularly during the early stages of treatment. To ensure patient comfort and compliance during
treatment, the prevention or management of pain is of major importance. While pharmacological means are the first line of treatment
for alleviation of orthodontic pain, a range of non-pharmacological approaches have been proposed recently as viable alternatives.
Objectives
To assess the effects of non-pharmacological interventions to alleviate pain associated with orthodontic treatment.
Search methods
Cochrane Oral Health’s Information Specialist searched the following databases: Cochrane Oral Health’s Trials Register (to 6 October
2016), the Cochrane Central Register of Controlled Trials (CENTRAL) (the Cochrane Library, 2016, Issue 9), MEDLINEOvid (1946
to 6 October 2016), Embase Ovid (1980 to 6 October 2016) and EThOS (to 6 October 2016). We searched ClinicalTrials.gov and
the World Health Organization International Clinical Trials Registry Platform for ongoing trials. No restrictions were placed on the
language or date of publication when searching the electronic databases.
Selection criteria
Randomised controlled trials (RCTs) comparing a non-pharmacological orthodontic pain intervention to a placebo, no intervention
or another non-pharmacological pain intervention were eligible for inclusion. We included any type of orthodontic treatment but
excluded trials involving the use of pre-emptive analgesia or pain relief following orthognathic (jaw) surgery or dental extractions in
combination with orthodontic treatment. We excluded split-mouth trials (in which each participant receives two or more treatments,
each to a separate section of the mouth) and cross-over trials.
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Data collection and analysis
At least two review authors independently assessed risk of bias and extracted data. We used the random-effects model and expressed
results as mean differences (MD) with 95% confidence intervals (CI). We investigated heterogeneity with reference to both clinical
and methodological factors.
Main results
We included 14 RCTs that randomised 931 participants. Interventions assessed included: low-level laser therapy (LLLT) (4 studies);
vibratory devices (5 studies); chewing adjuncts (3 studies); brain wave music or cognitive behavioural therapy (1 study) and post-
treatment communication in the form of a text message (1 study). Twelve studies involved self-report assessment of pain on a continuous
scale and two studies used questionnaires to assess the nature, intensity and location of pain.
We combined data from two studies involving 118 participants, which provided low-quality evidence that LLLT reduced pain at 24
hours by 20.27 mm (95% CI -24.50 to -16.04, P < 0.001; I² = 0%). LLLT also appeared to reduce pain at six hours, three days and
seven days.
Results for the other comparisons assessed are inconclusive as the quality of the evidence was very low. Vibratory devices were assessed
in five studies (272 participants), four of which were at high risk of bias and one unclear. Chewing adjuncts (chewing gum or a bite
wafer) were evaluated in three studies (181 participants); two studies were at high risk of bias and one was unclear. Brain wave music and
cognitive behavioural therapy were evaluated in one trial (36 participants) assessed at unclear risk of bias. Post-treatment text messaging
(39 participants) was evaluated in one study assessed at high risk of bias.
Adverse effects were not measured in any of the studies.
Authors’ conclusions
Overall, the results are inconclusive. Although available evidence suggests laser irradiation may help reduce pain during orthodontic
treatment in the short term, this evidence is of low quality and therefore we cannot rely on the findings. Evidence for other non-
pharmacological interventions is either very low quality or entirely lacking. Further prospective research is required to address the lack
of reliable evidence concerning the effectiveness of a range of non-pharmacological interventions to manage orthodontic pain. Future
studies should use prolonged follow-up and should measure costs and possible harms.
P L A I N L A N G U A G E S U M M A R Y
Techniques for reducing pain during orthodontics without using painkillers
Review question
Orthodontic treatment (teeth braces) can be painful, particularly following initial brace placement and later adjustments, for a week
or more. We examined the merits of methods to reduce pain during orthodontic treatment without the need for painkillers.
Background
Pain is usual during orthodontic treatment and may make some people stop treatment early, meaning that planned benefits do not
occur. Painkillers are recommended to reduce pain during orthodontic treatment, but an effective non-drug solution would lower risks
of side effects and help people to continue for the full course of treatment.
Search date
We included studies published before 6 October 2016.
Study characteristics
We included 14 studies that involved a total of 931 teenagers and adults. The studies investigated the effects of using laser irradiation
provided by the orthodontist, vibratory devices, changing chewing patterns (patients chewing gum or wafers), brain wave music,
cognitive behavioural therapy, and text messages to support people after braces were fitted. The main outcome measured was the
intensity of pain over the short term as reported by patients.
Key results
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We found insufficient evidence to assess the effectiveness of the interventions, although the available low-quality evidence suggested
that laser irradiation may help to control short-term orthodontic pain. None of the studies considered side effects of the treatments. We
identified relatively few studies, some of which used flawed methods or were not well reported. More research to look at the possible
merits of non-drug methods of pain control would be helpful. Future studies should measure pain over longer time periods and should
measure side effects and costs.
Quality of the evidence
The quality of the evidence on the effectiveness of non-drug ways to ease orthodontic pain was low to very low, so we are not able to
rely on the findings.
3Non-pharmacological interventions for alleviating pain during orthodontic treatment (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Low-level laser therapy versus placebo
Patient or population: adolescents and adults undergoing orthodont ic treatment
Setting: university
Intervention: low-level laser therapy
Comparison: placebo
Outcomes Anticipated absolute effects∗ (95% CI) Relative effect
(95% CI)
Number of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Absolute effect in con-
trol
M ean difference (M D)
low- level laser therapy
compared to control
Patient- reported pain
intensity or pain relief
VAS (1 mm to 100 mm)
- 24 hours
36 to 55.47 Mean pain intensity in
the intervent ion group
was 20.27 mm lower
(24.50 lower to 16.04
lower)
- 118
(2 RCTs)
⊕⊕©©
low a,b
At 6 hours, a sensit ivity
analysis removing the
study at unclear risk of
bias showed ef fect ive-
ness of laser therapy:
MD -17.90 mm, 95% CI
-28.80 to -7.00
At 3 days, MD was -10.
76 mm, 95% CI -13.80
to 7.73 mm
At 7 days, MD was -6.
39 mm, 95% CI -8.65 to
-4.13 (1 study, 58 par-
t icipants)
Adverse effects Not measured
* The risk in the intervention group (and its 95% conf idence interval) is based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its
95% CI)
CI: conf idence interval; VAS: visual analogue scale
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GRADE Working Group grades of evidence
High quality: we are very conf ident that the true ef fect lies close to that of the est imate of the ef fect
M oderate quality: we are moderately conf ident in the ef fect est imate: the true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
substant ially dif f erent
Low quality: our conf idence in the ef fect est imate is lim ited: the true ef fect may be substant ially dif f erent f rom the est imate of the ef fect
Very low quality: we have very lit t le conf idence in the ef fect est imate: the true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
a Downgraded one level for imprecision
b Downgraded one level for risk of bias
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B A C K G R O U N D
Description of the condition
Orthodontics is a specialty within dentistry concerned with the
treatment of malocclusion, which can be a result of dento-alveolar
disproportion (most commonly crowding), disproportionate jaws
or a combination of the two. The ultimate goal of orthodontics is
to create a balanced facial profile with aligned teeth and optimal
dental occlusion leading to better aesthetics and function. Tooth
movement, which is needed to reach this goal, is possible through
the application of light forces in patients of all ages. A wide variety
of orthodontic appliances, fixed or removable, can be used for this
purpose. Fixed appliances are attached to teeth with adhesive, and
cannot be removedby the patient for the durationof the treatment.
Pain is an unpleasant sensory and emotional experience associated
with actual or potential tissue damage (Bonica 1979). The forces
required for tooth movement are often associated with discom-
fort or pain, as tooth movement is only possible through a pro-
cess of inflammation. During inflammation, various biochemical
mediators are released which are responsible for the sensation of
pain. Pain during orthodontic treatment can be dependent on age
(Bergius 2000; Brown 1991; Jones 1985), gender (Bergius 2000;
Ngan 1989), psychological well-being (Bergius 2000; Sergl 1998),
culture (Bergius 2000), and previous pain experiences (Bergius
2000; Firestone 1999; Ngan 1989). This makes pain subjective.
Pain has been reported in 70% to 94% of orthodontic patients
during treatment (Firestone 1999; Kvam 1987; Oliver 1985;
Schreurer 1996); fixed appliances are associated with more pain
than removable appliances (Sergl 1998; Stewart 1997). During
fixed appliance-based treatment, orthodontic pain typically grad-
ually increases from two hours after the placement of the first arch
wire (Jones 1984; Schreurer 1996; Soltis 1971), peaking at 24
hours and then decreasing gradually, but may last from two days to
a week or more (Burstone 1962; Ngan 1989). In terms of severity,
orthodontic pain may range from slight discomfort during chew-
ing to a constant, throbbing pain. No specific arch wire or bracket
type has consistently been found to cause less pain (Jian 2013).
Description of the intervention
Management of orthodontic pain includes pharmacological and
non-pharmacological interventions. Various drugs are effective for
the management of pain during orthodontic treatment (Ngan
1994; Paganelli 1993; Simmons 1992), the most commonly used
class is non-steroidal anti-inflammatory drugs (NSAIDs). How-
ever, pharmacological or drug interventions may have some neg-
ative side effects and some patients may be unwilling to use then
or may be allergic to them. For these reasons, a large number of
non-pharmacological interventions have also been investigated to
alleviate orthodontic pain. Some examples of these are bite wafers
and chewing gum, low level laser therapy (LLLT), vibratory stimu-
lation, transcutaneous electrical nerve stimulation (TENS), appli-
cation of ice/cryotherapy, acupuncture/acupressure, and psycho-
logical interventions such as a structured telephone call to patients
during treatment.
How the intervention might work
LLLT is defined as laser treatment in which the energy produced
by the laser is low enough not to cause an increase in body temper-
ature. The laser produces a pure light with a single wave length that
stimulates the biological processes within the tissue being treated.
LLLT has anti-inflammatory effects which can result in pain relief
(Hashmi 2010).
The roots of teeth are surrounded by small fibres called periodontal
ligament (PDL) fibres that connect the teeth to the jaw bone. Ad-
junctive vibratory stimulation may increase vascularity and limit
ischaemia following orthodontic appliance placement activating
large-diameter sensory nerve fibres. This force is delivered via pro-
prietary devices which the patient bites into for short periods (usu-
ally around 20 minutes) on a daily basis. There is limited evidence
to support their clinical effectiveness. The theory behind the use
of bite wafers (Otasevic 2006) and chewing gum (Benson 2012)
is analogous to that underpinning the use of vibratory adjuncts.
Chewing on a bite wafer (or chewing gum) is postulated to lead to
loosening of the PDL fibres and an increase in blood flow to the ar-
eas surrounding the roots. This increase in blood flowmay prevent
or relieve inflammation, which in turn, relieves pain (Furstman
1972).
Cryotherapy is the use of low temperatures for medical treat-
ment, which also modulates pain transmission from tissues. It en-
hances capillary contraction and reduces the temperature of dam-
aged areas following trauma or surgery or both. Thus, cryother-
apy controls oedema by reducing permeability, haemorrhage and
metabolism (Movahedi 2006; Shin 2009). Acupuncture is a form
of traditional Chinese medicine. It is believed that the manipu-
lation of thin, solid needles inserted into so-called ’acupuncture
points’ in the skin can relieve certain types of pain. Acupressure
is based on acupuncture but involves application of physical pres-
sure, by hand, elbow, or with the aid of various devices to acupunc-
ture points on the surface of the body. Although both acupunc-
ture and acupressure are widely used to manage acute and chronic
pain, their methods of action and efficacy are not fully understood
(Cruccu 2007; Paley 2015; Vachiramon 2005). TENS is a form of
stimulation-produced analgesia. Two electrical conductors (elec-
trodes) are placed in direct contact with the painful teeth. An elec-
trical current is produced between the electrodes, which causes the
release of natural products and stimulates the nerves responsible
for the transmission of pain (Atamaz 2012).
Another non-pharmacological intervention mentioned in the lit-
erature is the use of a structured telephone call. Some theories im-
ply that psychological factors contribute to the perception of pain
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(Melzack 1965), and the literature shows a relationship between
anxiety andpain (Litt 1996; Schupp2005; Sergl 1998;Theunissen
2012). A structured telephone call can be used to reassure and
encourage patients to reduce anxiety and ultimately lead to pain
relief.
Why it is important to do this review
Pain, in general, motivates us to withdraw from potentially dam-
aging situations, protect a damaged body part while it heals, and
to avoid those situations in the future. Pain during orthodontic
treatment has been shown to be the most common reason for dis-
continuation of treatment (Kluemper 2002; Oliver 1985; Patel
1989), and accounts for why pain is a significant factor hindering
patient compliance (Brown 1991; Patel 1989; Sergl 1998). Or-
thodontic pain has also been linked with reduced levels of oral
hygiene (Soltis 1971;White 1984). To ensure patient comfort and
compliance during treatment, the prevention or management of
pain is of major importance. This review investigated non-phar-
macological interventions for alleviating pain during orthodontic
treatment. Pain relief following tooth extraction or surgical pro-
cedures associated with orthodontic treatment was not included.
O B J E C T I V E S
To assess the effects of non-pharmacological interventions to alle-
viate pain associated with orthodontic treatment.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included randomised controlled trials (RCTs) in which a non-
pharmacological pain intervention was compared concurrently
to a placebo, no intervention, or another non-pharmacological
pain intervention. RCTs that compared pharmacological and non-
pharmacological interventions to a placebo or no intervention
were included but only data for non-pharmacological interven-
tions were used. We excluded split-mouth studies (in which each
participant receives two or more treatments, each to a separate
section of the mouth), owing to the lack of independence of pain-
relieving interventions in different intra-oral sites.
Types of participants
We included people of any age undergoing any type of orthodon-
tic treatment. We excluded trials involving the use of pre-emp-
tive analgesia or pain relief following orthognathic (jaw) surgery
or dental extractions, or both in combination with orthodontic
treatment.
Types of interventions
We included the following active interventions to alleviate pain
either alone or in combination.
• Low-level laser therapy (LLLT).
• Vibratory adjuncts.
• Experimental chewing adjuncts, e.g. bite wafers and
chewing gum.
• Psychosocial and other interventions, e.g. verbal follow-up
and reassurance in the form of a structured telephone call, brain
wave music or cognitive behavioural therapy.
• Physical interventions such as transcutaneous electric nerve
stimulation (TENS), ice/cryotherapy and acupuncture/
acupressure.
Control: Any form of orthodontic treatment without the use of
a non-pharmacological technique to reduce subjective pain expe-
rience. Comparisons were made with placebo, or with the same
intervention but at a different dose or intensity, or at a different
time interval.
Types of outcome measures
Primary outcomes
• Patient-reported pain intensity or pain relief, as measured
on a visual analogue scale (VAS), numerical rating scale, or any
categorical scale.
Secondary outcomes
• Dose/intensity and frequency of pain relief needed.
• Any rescue medication (alternative pain relief taken or
prescribed, including dose and time, following the last
treatment).
• Adverse effects of pain treatment (ideally recorded both at
person and event level within each trial arm).
• Quality of life or satisfaction, or both.
• Time off school or work or both.
• Response to treatment (defined as reduction in pain by at
least 50%).
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Search methods for identification of studies
Electronic searches
Cochrane Oral Health’s Information Specialist conducted system-
atic searches in the following databases for randomised controlled
trials and controlled clinical trials. There were no language, pub-
lication year or publication status restrictions:
• Cochrane Oral Health’s Trials Register (searched 6 October
2016) (Appendix 1);
• Cochrane Central Register of Controlled Trials
(CENTRAL; 2016, Issue 9) in the Cochrane Library (searched 6
October 2016) (Appendix 2);
• MEDLINE Ovid (1946 to 6 October 2016) (Appendix 3);
• Embase Ovid (1980 to 6 October 2016) (Appendix 4);
• EThOS (http://ethos.bl.uk/) (to 6 October 2016)
(Appendix 5).
Subject strategies were modelled on the search strategy designed
for MEDLINE Ovid. The Embase search was combined with an
adapted version of the Cochrane Embase Project filter for identify-
ing RCTs in Embase Ovid (see http://www.cochranelibrary.com/
help/central-creation-details.html for information).
Searching other resources
Cochrane Oral Health’s Information Specialist searched the fol-
lowing trial registries for ongoing studies, see Appendix 6 for de-
tails of the search strategy:
• US National Institutes of Health Ongoing Trials Register
ClinicalTrials.gov (clinicaltrials.gov; searched 6 October 2016);
• World Health Organization International Clinical Trials
Registry Platform (apps.who.int/trialsearch; searched 6 October
2016).
We examined the reference lists of relevant articles to identify
additional published and unpublished relevant studies.
We did not perform a separate search for adverse effects of inter-
ventions used; we considered adverse effects described in included
studies only.
Data collection and analysis
Selection of studies
Two review authors (Hardus Strydom (HS) andPiotr Fudalej (PF))
independently assessed the titles and abstracts of studies identi-
fied through the searches. We obtained full copies of all studies
appearing to meet the inclusion criteria and those for which there
were insufficient data in the title and abstract to make a definitive
decision. Two review authors (HS and Padhraig Fleming (PSF))
assessed the full-text papers independently and resolved any dis-
agreement on the eligibility of included studies through discus-
sion with a third review author (Nikolaos Pandis (NP)). From this
group of studies, we recorded the studies that did not meet the
inclusion criteria in the Characteristics of excluded studies section
of the review and reported the reasons for exclusion.
Data extraction and management
We designed data extraction forms to record year of publication
and study setting, as well as details of the participants including
demographic characteristics and criteria for inclusion. We entered
study details into the Characteristics of included studies tables in
ReviewManager 5 (RevMan 2014). Two review authors (PSF and
PF) extracted data independently, with disagreements resolved by
consulting with a third review author. We extracted the following
details where available.
• Trial methods: (a) method of allocation; (b) masking of
participants, trialists and outcome assessors; (c) exclusion of
participants after randomisation; and proportion of, and reasons
for, losses at follow-up.
• Participants: (a) country of origin and study setting; (b)
sample size; (c) age; (d) gender; (e) inclusion and exclusion
criteria.
• Intervention: (a) type; (b) materials and techniques used;
(c) time of follow-up.
• Control: (a) type; (b) materials and techniques used; (c)
time of follow-up.
• Outcomes: (a) primary and secondary outcomes mentioned
in the Types of outcome measures section of this review. If
stated, we recorded the sources of funding. We planned to use
this information to aid assessment of heterogeneity and the
external validity of any included trial.
Assessment of risk of bias in included studies
Two review authors (PSF and NP) independently assessed risk of
bias in the included trials using Cochrane’s tool for assessing risk
of bias as described in section 8.5 of the Cochrane Handbook for
Systematic Reviews of Interventions (Higgins 2011). We compared
the assessments and resolved any disagreements through discus-
sion. We assessed the following domains as at low, high or unclear
risk of bias.
• Sequence generation (selection bias)
• Allocation concealment (selection bias)
• Blinding of participants and personnel (performance bias),
and outcome assessors (detection bias)
• Incomplete outcome data addressed (attrition bias)
• Selective outcome reporting (reporting bias)
• Other bias
We categorised and reported the overall risk of bias of each in-
cluded study according to the following.
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• Low risk of bias (plausible bias unlikely to seriously alter the
results) if all domains were assessed as at low risk of bias
• Unclear risk of bias (plausible bias that raises some doubt
about the results) if one or more domains were assessed as at
unclear risk of bias
• High risk of bias (plausible bias that seriously weakens
confidence in the results) if one or more domains were assessed as
at high risk of bias
Measures of treatment effect
For continuous outcomes including pain scores on 100 mm scales,
we calculated mean differences with 95% confidence intervals
(CI). In our protocol, we had planned to dichotomise pain re-
sults, but as most studies measured pain on a VAS, we decided
to use continuous data in order not to lose information. For di-
chotomous outcomes such as presence or absence of pain or use
of painkillers, we planned to calculate risk ratios with 95% CI.
Unit of analysis issues
We did not include split-mouth or cross-over trials. Where stud-
ies had more than one treatment group, we made necessary ad-
justments to the control group numbers in order to avoid double
counting participants.
Dealing with missing data
Where data were unclear or incomplete, we contacted the corre-
sponding authors. If missing data were unavailable, we followed
the advice outlined in section 16.1.2 of theCochrane Handbook for
Systematic Reviews of Interventions (Higgins 2011). In case of the
use of ’rescue medication’, we had planned to use two imputation
methods to calculate estimate of pain relief.
• Baseline observation carried forward (BOCF) - the pain
relief score is set to zero for all remaining time points from rescue
medication until the end of the observation period.
• Last observation carried forward (LOCF) - the last pain
relief measurement, at the observation immediately preceding
remedication, is used for all remaining assessments.
Assessment of heterogeneity
We assessed clinical heterogeneity by considering the character-
istics of the studies, similarity between the types of participants,
and interventions and outcomes assessed. We assessed statistical
heterogeneity using a Chi² test and the I² statistic, where I² values
of 30% to 60% might indicate moderate heterogeneity, 50% to
90% substantial heterogeneity, and 75% to 100% very substantial
(’considerable’) heterogeneity. We considered heterogeneity to be
significant when the P value was below 0.10 (Higgins 2011).
Assessment of reporting biases
If a sufficient number of studies assessing similar interventions
were to be identified for inclusion in future review updates, we
would assess publication bias based on the recommendations for
testing funnel plot asymmetry as described in section 10.4.3.1
of the Cochrane Handbook for Systematic Reviews of Interventions
(Higgins 2011). If asymmetry was to be identified, we would at-
tempt to assess other possible causes and explore these in the dis-
cussion if appropriate.
Data synthesis
We pooled data from studies with similar participants, interven-
tions and outcomes. We calculated a weighted treatment effect
with the results expressed asmean difference (MD), when different
scales for the same outcome were used and 95% CI for continuous
outcomes. We used random-effects models for meta-analyses.
Subgroup analysis and investigation of heterogeneity
Where we found significant heterogeneity, we had planned to con-
duct the following subgroup analyses to explore the source, in-
cluding:
• type of interventions;
• dose or intensity of interventions;
• participants’ characteristics: age, gender, ethnicity,
psychological well-being and previous pain experienced; and
• type of orthodontic appliance used.
We will include these in future updates of this review if there are
sufficient data.
Sensitivity analysis
We undertook sensitivity analysis based on risk of bias (low risk of
bias versus high or unclear risk of bias) to investigate the robustness
of conclusions.
Summary of results
We produced ’Summary of findings’ tables for the main compar-
isons and primary outcomes of this review using the GRADE sys-
tem (Guyatt 2008) with GRADEpro software.
We assessed the quality of the body of evidence with reference to
the following.
• Overall risk of bias of the included studies.
• Indirectness of the evidence.
• Inconsistency of the results.
• Imprecision of the estimates.
• Risk of publication bias.
• Magnitude of the effect.
We categorised the quality of the body of evidence for each of the
primary outcomes as high, moderate, low, or very low.
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R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies.
Results of the search
The electronic searches yielded 739 records, and two were found
from other sources. After removal of duplicates, 471 records were
screened by title and abstract for eligibility. We identified 28
potentially relevant studies and obtained the full-text articles.
After assessment of the full texts, we excluded 13 studies (see
Characteristics of excluded studies). We are waiting for more in-
formation about one study (see Characteristics of studies awaiting
classification). We included 14 studies in this review (Figure 1).
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Figure 1. Study flow diagram
11Non-pharmacological interventions for alleviating pain during orthodontic treatment (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Included studies
Characteristics of the trial settings and investigators
Twelve studies were carried out in university and hospital settings
and two were undertaken in a private practice setting (Miles 2012;
Miles 2016).
Nine studies were two-group parallel studies; one study was a
three-arm trial (Huang 2016); three studies involved four parallel
groups (Harazaki 1997; Kim 2013; Woodhouse 2015); and one
study involved five groups (Farzanegan 2012).
Characteristics of the participants
A total of 931 participants were randomised in the 14 studies.
Around 860 of the participants were analysed (this is an estimate
as one study did not specify the number of evaluated participants).
The studies involved both adolescents and adults, with partici-
pants under the age of 16 years included in two studies (Miles
2012; Otasevic 2006) and adolescents up to 18 years included
in three studies (Benson 2012; Farzanegan 2012; Keith 2013).
Participants were deemed to require orthodontic treatment with
fixed appliances. Comorbidity, chronic pain conditions and reg-
ular consumption of pain medications were common exclusion
criteria. Participants required orthodontic extraction of four pre-
molars in Farzanegan 2012, mandibular first premolar extraction
in Woodhouse 2015, while suitability for non-extraction treat-
ment in the mandibular arch was a requirement for inclusion in
Miles 2012 andMiles 2016. Participants had recently commenced
fixed appliance treatment, with pain assessment undertaken over
the first week of appliance therapy in 10 studies (Benson 2012;
Farzanegan 2012; Huang 2016; Keith 2013; Kim 2013; Lobre
2015; Marie 2003, Miles 2012; Miles 2016; Otasevic 2006). Pain
experience was assessed in the first week following placement of
orthodontic separators in one study (Nobrega 2013). In two stud-
ies (Benson 2012; Lobre 2015), assessment was undertaken both
following separator placement, following initial fixed appliance
placement, and subsequent to later fixed appliance adjustments ei-
ther over the initial fourmonths of appliance therapy (Lobre 2015)
or until working stainless steel arch wires were engaged (Benson
2012). In a further study, pain experienced following the initial
two adjustments was considered (Woodhouse 2015).
Characteristics of the interventions
The interventions assessed four main approaches: low-level laser
therapy (LLLT) irradiation; vibratory adjuncts; experimental
chewing adjuncts; and psychosocial approaches (post-treatment
text messaging, brain wave music and cognitive behavioural ther-
apy).
LLLT was used in four studies (Harazaki 1997; Kim 2013;
Nobrega 2013; Turhani 2006).
Vibratory devices were used in five studies (Lobre 2015; Marie
2003; Miles 2012; Miles 2016; Woodhouse 2015), using the
AcceleDent Aura micropulse device, used for 20 minutes daily
throughout the study period (Lobre 2015; Woodhouse 2015;
Miles 2016), theToothMasseusefor 20minutes daily (Miles 2012)
or Good Vibrations for 15 minutes daily (Marie 2003).
The influence of experimental changes in chewing behaviour was
assessed in three studies (Benson 2012; Farzanegan 2012; Otasevic
2006), with chewing gumused in two throughout the study period
(Benson 2012; Farzanegan 2012). Bite wafers were used in two
intervention groups in Farzanegan 2012 and by Otasevic 2006
throughout the seven-day study periods.
Pain reduction using either brain wave music or cognitive be-
havioural therapy was assessed in one trial (Huang 2016)
Post-treatment communication in the form a text message was
carried out in one study (Keith 2013).
Control conditions
In all studies, control group participants received conventional
fixed appliance-based orthodontic treatment without the use of
non-pharmacological approaches to reduce pain.
Placebo control groups were used in six studies. Farzanegan 2012
incorporated consumption of a vitamin B tablet immediately
after arch wire placement and at eight-hour intervals for a week
if pain persisted. Nobrega 2013 used placebo irradiation with in-
frared light administered in an identical fashion to that received
by intervention group participants. Turhani 2006 reports using
placebo laser without active irradiation. Kim 2013 incorporated
a group submitted to LED irradiation in a manner similar to the
LLLT intervention group. The LED device worked on a wave
length of 635 nMwith 12.9 mWoutput from a device that looked
the same as the LLLT design. Harazaki 1997 included a placebo
group whose treatment involved use of a laser probe positioned
intra-orally to simulate delivery of LLLT. Woodhouse 2015 in-
corporated a sham used in the same way as the active AcceleDent
micropulse device (as well as a control group undergoing standard
treatment without use of either an active vibratory adjunct or a
sham).
Dietary changes were recommended for control group participants
in two studies. Benson 2012 suggested avoiding chewing gum and
Otasevic 2006 recommended that participants avoid both chewing
for three hours following appliance placement and hard foods for
the seven-day study period.
12Non-pharmacological interventions for alleviating pain during orthodontic treatment (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
No alternative interventions or placebos were included in six stud-
ies (Huang 2016; Keith 2013; Lobre 2015; Marie 2003; Miles
2012; Miles 2016). Miles 2012 andMiles 2016 used no vibration
for control groups participants; Keith 2013 used no text messag-
ing; Huang 2016 Lobre 2015 and Marie 2003 did not use any
interventions.
Characteristics of the outcomes
Twelve studies assessed pain scores on a continuous scale (Benson
2012; Farzanegan 2012; Huang 2016; Keith 2013; Kim 2013;
Lobre 2015;Marie 2003,Miles 2012;Miles 2016; Nobrega 2013;
Otasevic 2006; Woodhouse 2015). In the study report, Marie
2003 included only one figure and no usable data. Otasevic 2006
presented median values only, without a measure of dispersion.
Questionnaires assessing pain experience, quality, intensity and
location were used in two studies (Harazaki 1997; Turhani 2006).
The use of analgesics was recorded in three studies (Benson 2012;
Keith 2013; Otasevic 2006). Associated morbidity related to pain
was considered in two studies with the total impact score of the
appliance (Benson 2012) and the impact of the appliance on
oral function assessed (Farzanegan 2012). Pain assessments were
recorded at multiple time intervals during the first week of ap-
pliance therapy in all studies. In Lobre 2015, assessments were
undertaken over the initial four months of appliance placement
on a daily basis for the first week following appliance adjustment
and then weekly over the remainder of the month. Pain was also
assessed both at the beginning of treatment and throughout the
alignment phase in Benson 2012.
Excluded studies
We excluded 13 studies; eight were split-mouth studies (Abtahi
2013; Artés-Ribas 2013; Bicacki 2012; Domínguez 2013; Doshi-
Mehta 2012; Eslamian 2014; Lim 1995; Marini 2013); three ap-
plied ineligible study designs (Bartlett 2005; Esper 2011; Roth
1986); and two studied populations that were not relevant to this
review (Gasperini 2014; Murdock 2010). See Characteristics of
excluded studies.
Risk of bias in included studies
Only one study was assessed at low risk of bias (Nobrega
2013); six studies were graded at unclear risk of bias (Farzanegan
2012; Harazaki 1997; Huang 2016; Kim 2013; Turhani 2006;
Woodhouse 2015); and seven studies were judged at high risk of
bias (Benson 2012; Keith 2013; Lobre 2015; Marie 2003; Miles
2012; Miles 2016; Otasevic 2006). Further details of risk of bias
assessments are presented in theCharacteristics of included studies
section. Overall ratings are graphically presented in Figure 2 and
Figure 3.
Figure 2. Risk of bias graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies
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Figure 3. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study
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Allocation
Random sequence generation
The methods used to generate the allocation sequence and the
method of concealing the sequence, such that participants and
investigators enrolling participants could not foresee the next as-
signment, are key indicators for minimising bias in a clinical trial
(Schulz 1995). The method was clear and adequate in eight stud-
ies (Benson 2012; Farzanegan 2012; Huang 2016; Lobre 2015;
Miles 2012; Miles 2016; Nobrega 2013; Woodhouse 2015) and
unclear in six studies (Harazaki 1997; Keith 2013; Kim 2013;
Marie 2003; Otasevic 2006; Turhani 2006).
Allocation concealment
Concealment of the allocation sequence was undertaken and
described in six of the included studies (Benson 2012; Huang
2016; Lobre 2015; Miles 2016; Nobrega 2013; Woodhouse
2015). We assessed allocation concealment as unclear in five stud-
ies (Farzanegan 2012; Harazaki 1997; Kim 2013; Miles 2012;
Turhani 2006) and at high risk of bias in three studies (Keith 2013;
Marie 2003; Otasevic 2006).
Blinding
Blinding of participants was important for this review because the
main outcome was self-assessed pain; however, the complexity of
blinding both participants and personnel to the interventions is
acknowledged. Some studies stated that participants and person-
nel were blinded, but the means used to attempt blinding had po-
tential to be discerned by participants; for example, some studies
used a control that could potentially be distinguished from the
intervention, or attempted blinding by withholding some details
about the study (see Characteristics of included studies). In the
five studies where these situations were reported, we assessed risk
of bias for blinding as unclear (Farzanegan 2012; Huang 2016;
Keith 2013; Turhani 2006; Woodhouse 2015). Placebos likely to
provide effective blinding were provided in four studies, which we
assessed as low risk of bias (Harazaki 1997; Kim 2013; Nobrega
2013; ). In the six studies where blinding was not attempted (for
example, blinding of participants to the use of adjuncts to simu-
late chewing was not possible) or could be very easily broken, we
assessed the risk of bias as high (Benson 2012; Lobre 2015; Marie
2003; Miles 2012; Miles 2016; Otasevic 2006).
Incomplete outcome data
We judged risk of attrition bias to be at low in 11 of the in-
cluded studies; there were no drop-outs reported in seven stud-
ies (Harazaki 1997; Huang 2016; Keith 2013; Kim 2013; Miles
2016; Nobrega 2013; Turhani 2006). High drop-out rates were
reported, but reasons were not provided in Otasevic 2006, which
we judged to be at high risk of bias. Farzanegan 2012 and Marie
2003 were assessed as unclear risk of bias for this domain.
Selective reporting
Although a study protocol was available for only one study
(Nobrega 2013), in general, outcomes listed in the studies ’Meth-
ods’ sections were comparable to the reported results.We therefore
assessed the included studies as being at low risk of reporting bias.
Other potential sources of bias
There was no reason for concern about other potential sources
of bias in 11 of the included studies; the risk of other bias was
considered unclear in three studies due to a lack of detail relating
to baseline characteristics and the nature of the interventions and
outcomes in the methods section (Harazaki 1997; Lobre 2015;
Marie 2003).
Effects of interventions
See: Summary of findings for the main comparison Low-level
laser therapy versus placebo; Summary of findings 2 Vibratory
stimulation versus control; Summary of findings 3Chewing gum
or bite wafer versus control; Summary of findings 4 Brain wave
music or cognitive behavioural therapy versus control; Summary
of findings 5 Post-treatment text message versus no text
See: Summary of findings table 1; Summary of findings 2;
Summary of findings 3; Summary of findings 4. No studies eval-
uated TENS; ice orcryotherapy; acupuncture or acupressure.
Low-level laser therapy versus placebo
Patient-reported pain intensity or pain relief measured on a
VAS or other scale
Low-level laser therapy (LLLT) versus placebo was assessed in two
studies with 118 participants (Kim 2013, assessed at unclear risk
of bias, and Nobrega 2013, assessed at low risk of bias) (Analysis
1.1). We assessed the evidence for this comparison as low quality
owing to imprecision and the risk of bias. Time points included
in the meta-analyses were six hours, one day, three days and seven
days. LLLT reduced pain compared to placebo atmost time points.
At six hours, the mean reduction on the VAS for irradiation was
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MD -10.63 mm (95%CI -22.33 to 1.07), although heterogeneity
was substantial (I² = 78%). A sensitivity analysis conducted by
removing Kim 2013 showed effectiveness of irradiation (MD -
17.90, 95% CI -28.80 to -7.00; P < 0.001). LLLT also reduced
pain at one day (MD -20.27 mm, 95% CI -24.50 to -16.04; P
< 0.001; I² = 9%; 2 studies, 118 participants); three days (MD
-10.76 mm, 95% CI -13.80 to -7.73; P < 0.001; I² = 0%; two
studies, 118 participants); and seven days (MD -6.39 mm, 95%
CI -8.65 to -4.13; P < 0.001; one study, 58 participants).
Two other studies (160 participants in total) assessing this compar-
ison used bespoke assessments and different interventions. They
were assessed at unclear risk of bias. Harazaki 1997 (84 partici-
pants) used a laser and assessed the onset of pain based on a five-
point scale, the proportion of patients experiencing severe pain,
the level of pain at the outset, and the day at which pain disap-
peared. The percentage of participants reporting severe pain upon
appliance activation was slightly lower in the intervention group
than the placebo group, although inferential statistical analysis was
not undertaken. Turhani 2006 (76 participants) also assessed the
effectiveness of LLLT and reported fewer participants experienc-
ing pain at 6 hours (P < 0.05) and 30 hours (P < 0.05), although
no effect was observed at 54 hours.
Secondary outcomes
The secondary outcomes were not assessed for this comparison.
Vibratory stimulation versus placebo vibration or no
vibration
Patient-reported pain intensity or pain relief measured on a
VAS or other scale
Three studies (two at high risk of bias and one unclear) involving
154 participants provided short-term data for this comparison
(Miles 2012;Miles 2016;Woodhouse 2015) (Analysis 2.1). Lobre
2015 provided longer-term data. Marie 2003 (a study at high risk
of bias) also assessed vibratory devices but did not provide usable
data. We assessed the evidence for this comparison as very low
quality owing to imprecision and the risk of bias. There was no
evidence that vibratory stimulation reduced pain at any of the
time points assessed (Analysis 2.1; Analysis 2.2). At six hours, the
mean reduction on the 100 mm VAS was -0.52 mm (95% CI -
9.41 to 8.36; P = 0.91; 2 trials, 115 participants). No statistical
heterogeneity was found (I² = 0%). Similar findings were observed
at 24 hours (MD 1.32 mm, 95% CI -11.79 to 14.43; P = 0.84; 3
trials, 154 participants; I² = 59%), three days (MD .82 mm; 95%
CI -5.12 to 8.76; P = 0 .61; 3 trials, 154 participants; I² = 7%)
and also at seven days (MD 1.28 mm; 95% CI -3.16 to 5.71; P =
0.57; 3 trials, 154 participants; I² = 39%).
Longer follow-up was carried out in Lobre 2015 (high risk of bias)
and Woodhouse 2015 (unclear risk of bias). Lobre 2015 found
mean pain during the first four months of treatment appeared to
be lower in the intervention group at two time points: mean overall
pain intensity was 8.49 mm lower on the VAS during the second
month (P = 0.04) and 6.26 mm lower during the fourth month
(P = 0.03), with no evidence of benefit at month one and month
three (Analysis 2.2). Woodhouse 2015 assessed pain experience
for seven days following engagement of two arch wires (0.014 inch
and 0.018 inch NiTi) and did not find evidence of a benefit for
the intervention at any time point (Analysis 2.3).
Secondary outcomes
Dose/intensity and frequency of pain relief needed
Woodhouse 2015 assessed analgesic consumption over a one-week
period after both visits and found no statistical difference between
the intervention groups either after visit 1 (P = 0.533) or visit 2
(P = 0.901) with 72%, 60% and 73% of participants requiring
analgesia in the AcceleDent Aura, sham, and control groups fol-
lowing the first visit, respectively. These findings were mirrored
following the second visit, although the prevalence of analgesic use
was much lower (32% to 38%). Specifically for the comparison
between AccelDent Aura and control the results for visit 1 and
visit 2 were RR 0.99, 95% CI 0.72 to 1.37, P = 0.96, and RR
1.00, 95% CI 0.46 to 2.20, P = 0.99.
Data in relation to analgesic consumption was provided by Miles
2016 (see Analysis 2.4), however data were presented at specific
timepoints (6 hours, 24 hours, 3 days and 7 days) after placement
of the appliance. Miles 2016 noted statistically less analgesic use
in the intervention group at 24 hours (RR 0.63, 95% CI 0.44
to 0.92; P < 0.01), however no statistically significant differences
were identified at six hours (RR 1.00, 95% CI 0.43 to 2.33; P =
0.72), three days (RR 0.75, 95% CI 0.19 to 2.93; P = 0.68) or
seven days (RR 0.33, 95% CI 0.02 to 7.02; P = 0.31).
None of the other secondary outcomes were assessed.
Chewing adjuncts (chewing gum or wafer) versus no
chewing gum or placebo
Patient-reported pain intensity or pain relief measured on a
VAS or other scale
The effect of chewing adjuncts was assessed in three trials (Benson
2012, high risk of bias; Farzanegan 2012, unclear risk of bias;
Otasevic 2006, high risk of bias) that enrolled a total of 191 par-
ticipants. We assessed the evidence for this comparison as very low
quality owing to inconsistency, imprecision and the risk of bias.
Otasevic 2006 analysed 84 participants and presentedmedian val-
ues only with nomeasure of dispersion. Otasevic 2006 stated find-
ing higher median pain in the bite wafer group compared to the
group who avoided chewing at one day (P = 0.006). Farzanegan
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2012 included three relevant intervention groups versus control
(we adjusted the control sample size downwards in our three com-
parisons to avoid double counting participants). Based on a sin-
gle study with evaluable data from 39 participants (Farzanegan
2012), the mean reduction in the VAS score at six hours was not
statistically significant (VAS 1.39 mm, 95% CI -3.24 to 0.64; P
= 0.18; I² = 0%). However, at 24 hours and three days, statisti-
cally significant differences were found. At 24 hours, there was a
mean decrease of 15.38 mm (95% CI -28.90 to -1.86; P = 0.03;
I² = 14%), based on two trials involving data for 96 participants
(Benson 2012; Farzanegan 2012). At three days, themean decrease
was 29.16 mm (95% CI -51.67 to -6.65), although this result
was based on a single study (Farzanegan 2012). At seven days, the
mean reduction was not statistically significant (VAS 15.17 mm,
95% CI -32.44 to 2.11; P = 0.09; I² = 46%; 2 trials, 96 partici-
pants). See Analysis 3.1.
Secondary outcomes
Dose/intensity and frequency of pain relief needed
Analgesic consumption was assessed in Benson 2012 (57 partici-
pants). There were no statistically significant differences between
the groups at 24 hours (P = 0.903) or at one week (P = 0.104).
Quality of life or patient satisfaction
The impact of the appliances and associated pain on oral func-
tion was assessed in two studies (Benson 2012; Farzanegan 2012;
107 participants in total). The severity of pain was recorded dur-
ing four oral functions including chewing, occlusion of posterior
teeth, and occlusion of anterior teeth (Farzanegan 2012), with lit-
tle difference observed among groups. Benson 2012 reported that
the global impact of the appliance was lower in the chewing gum
group 24 hours after appliance placement (RR 0.45, 95% CI 0.22
to 0.94; P = 0.03), although this difference dissipated by seven
days (RR 0.68, 95% CI 0.30 to 1.53; P = 0.35) (Analysis 3.2).
In terms of total impact scores, the median score was 16 lower in
the chewing gum group at 24 hours (P = 0.031). By seven days,
the between-groups difference was not statistically significant (P
= 0.185).
No data were available for other secondary outcomes.
Brain wave music or cognitive behavioural therapy
versus no special instructions
Patient-reported pain intensity or pain relief measured on a
VAS or other scale
The potential benefits of brain wave music and cognitive be-
havioural therapy on pain experience was assessed in one study at
unclear risk of bias, which involved 36 participants (Huang 2016;
Analysis 4.1). We assessed the quality of evidence for this compar-
ison as very low owing to imprecision and the possible risk of bias.
Brain wave music was shown to reduce pain at 24 hours (MD -
26.65 mm, 95% CI -39.06 to -14.24; P < 0.001) and three days
(MD -23.44 mm, 95% CI -36.82 to -10.06; P < 0.001). No sta-
tistically significant effect was observed at seven days (MD -4.72
mm, 95% CI -15.83 to 6.39; P = 0.41).
Similarly, cognitive behavioural therapy was also shown to be ef-
fective at 24 hours (MD -20.67 mm, 95% CI -32.12 to -9.22; P <
0.001) and three days (MD -27.91mm, 95%CI -40.10 to -15.72;
P < 0.001), but had no statistically significant effect at seven days
(MD -6.50 mm, 95% CI -17.64 to 4.64; P = 0.25).
Secondary outcomes
No data were available for the secondary outcomes.
Post-treatment communication (text messaging)
versus no communication
Patient-reported pain intensity or pain relief measured on a
VAS or other scale
Pain experience was assessed over a seven-day period in one study
at high risk of bias, with 39 participants (Keith 2013).We assessed
the evidence for this comparison as very low quality owing to
imprecision and high risk of bias. Less pain was observed in the
intervention group at two, three, four and five days (P < 0.05)
following appliance placement, although no difference was found
between groups at four hours, six days or seven days (Analysis 5.1).
Secondary outcomes
No data were available for the secondary outcomes.
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A D D I T I O N A L S U M M A R Y O F F I N D I N G S [Explanation]
Vibratory st imulat ion versus control
Patient or population: adolescents and adults undergoing orthodont ic treatment
Setting: university and private pract ice
Intervention: vibratory st imulat ion
Comparison: no intervent ion or placebo vibrat ion
Outcomes Anticipated absolute effects∗ (95% CI) Relative effect
(95% CI)
Number of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Absolute effect in con-
trol
M ean difference (M D)
with vibratory stimula-
tion compared to con-
trol
Patient- reported pain
intensity or pain relief
VAS (1 mm to 100 mm)
- 24 hours
47.6 to 57.65 Mean pain intensity in
the intervent ion group
was 1.32 mm higher
(11.79 lower to 14.43
higher)
- 154
(3 RCTs)
⊕⊕©©
very low a,b
Insuf f icient evidence to
determ ine whether this
intervent ion was ef fec-
t ive or not at all t ime-
points
Adverse effects Not measured
* The risk in the intervention group (and its 95% conf idence interval) is based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its
95% CI).
CI: conf idence interval; VAS: visual analogue scale
GRADE Working Group grades of evidence
High quality: we are very conf ident that the true ef fect lies close to that of the est imate of the ef fect
M oderate quality: we are moderately conf ident in the ef fect est imate: the true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
substant ially dif f erent
Low quality: our conf idence in the ef fect est imate is lim ited: the true ef fect may be substant ially dif f erent f rom the est imate of the ef fect
Very low quality: we have very lit t le conf idence in the ef fect est imate: the true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
a Downgraded two levels for imprecision
b Downgraded one level for risk of bias1
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Chewing gum or bite wafer versus control
Patient or population: adolescents undergoing orthodont ic treatment
Setting: university and hospital
Intervention: chewing gum or wafer
Comparison: placebo or no chewing gum
Outcomes Anticipated absolute effects∗ (95% CI) Relative effect
(95% CI)
Number of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Absolute effect in con-
trol
M ean difference (M D)
with chewing gum or
wafer compared to
control
Patient- reported pain
intensity or pain relief
VAS upon chewing (1
mm to 100 mm) - 24
hours
41.6 to 74.7 Mean pain intensity in
the intervent ion group
was15.38 mm lower
(28.90 lower to 1.86
lower)
- 96
(2 RCTs)
⊕©©©
very low a,b,c
Insuf f icient evidence to
determ ine whether this
intervent ion was ef fec-
t ive or not at all t ime
points
Adverse effects Not measured
* The risk in the intervention group (and its 95% conf idence interval) is based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its
95% CI).
CI: conf idence interval; VAS: visual analogue scale; mm: millimetre
GRADE Working Group grades of evidence
High quality: we are very conf ident that the true ef fect lies close to that of the est imate of the ef fect
M oderate quality: we are moderately conf ident in the ef fect est imate: the true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
substant ially dif f erent
Low quality: our conf idence in the ef fect est imate is lim ited: the true ef fect may be substant ially dif f erent f rom the est imate of the ef fect
Very low quality: we have very lit t le conf idence in the ef fect est imate: the true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
a Downgraded one level for imprecision
b Downgraded one level for risk of bias
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c Downgraded one level for inconsistency. Otasevic 2006 did not provide data suitable for meta-analysis but reported higher
pain in intervent ion group than control.
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Brain wave music (BWM) or cognit ive behavioural therapy (CBT) versus control
Patient or population: adults undergoing orthodont ic treatment
Settings: university
Intervention: BWM or CBT
Comparison: no special instruct ions
Outcomes Anticipated absolute effects∗ (95% CI) Relative effect
(95% CI)
No of Participants
(studies)
Quality of the evidence
(GRADE)
Comments
Absolute effect in con-
trol
M ean difference (M D)
with BM W or CBT com-
pared to control
Patient- reported pain
intensity or pain relief:
VAS (1 mm to 100 mm)
- BWM vs control - 24
hours
53.83 Mean patient-reported
pain intensity in the in-
ter-
vent ion group was26.
65 mm lower (39.06
lower to 14.24 lower)
24
(1 RCT)
⊕©©©
very low a,b
Insuf f icient evidence to
determ ine whether this
intervent ion was ef fec-
t ive or not at all t ime-
points
Adverse effects for
BWM
Not measured
Patient- reported pain
intensity or pain relief:
VAS (1 mm to 100 mm)
- CBT vs control - 24
hours
53.83 Mean patient-reported
pain intensity in the in-
ter-
vent ion group was20.
67 mm lower (32.12
lower to 9.22 lower)
24
(1 RCT)
⊕©©©
very low a,b
Insuf f icient evidence to
determ ine whether this
intervent ion was ef fec-
t ive or not at all t ime-
points
Adverse effects for
CBT
Not measured
* The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% conf idence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its 95% CI).
CI: conf idence interval; VAS: visual analogue scale; BWM : brain wave music; CBT: cognit ive behavioural therapy21
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GRADE Working Group grades of evidence
High quality: we are very conf ident that the true ef fect lies close to that of the est imate of the ef fect
M oderate quality: we are moderately conf ident in the ef fect est imate: the true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
substant ially dif f erent
Low quality: our conf idence in the ef fect est imate is lim ited: the true ef fect may be substant ially dif f erent f rom the est imate of the ef fect
Very low quality: we have very lit t le conf idence in the ef fect est imate: the true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
a Downgraded two levels for imprecision
b Downgraded one level for unclear risk of bias
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Post-treatment text message compared with no text message for alleviat ing orthodont ic pain
Patient or population: people undergoing orthodont ic treatment
Settings: university
Intervention: text message
Comparison: no text message
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of Participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Patient- reported pain
intensity or pain relief:
VAS (1 mm to 100 mm)
- 24 hours
Not measured 39 (1 RCT) ⊕©©©
very low a,b
Insuf f icient evidence to
determ ine whether this
intervent ion was ef fec-
t ive or not at all t ime-
points
Adverse effects Not measured
a Downgraded two levels for imprecision
b Downgraded one level for high risk of bias
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D I S C U S S I O N
Summary of main results
We included 14 randomised controlled trials (RCTs), one at low
risk of bias, six at unclear risk of bias, and seven at high risk of
bias. The 14 studies enrolled 931 participants, of whom around
860 were included in analyses. The studies investigated a range
of interventions including low-level laser therapy (LLLT), vibra-
tory stimulation, chewing adjuncts, brain wave music, cognitive
behavioural therapy, and text messaging. Pain analyses were con-
fined to the first week following separator or fixed appliance place-
ment in 11 studies. in terms of the other three studies, Lobre 2015
followed-up for up to four months, Woodhouse 2015 included
more than one appliance adjustment, and Benson 2012) consid-
ered overall duration of orthodontic alignment.
Low-level laser therapy versus placebo or no
irradiation
There is low-quality evidence that the use of LLLT reduced self-
reported pain levels on a visual analogue scale (VAS) at six hours, 24
hours, three days and seven days after appliance placement. There
was insufficient evidence to determine effects on the secondary
outcomes of this review.
Vibratory stimulation versus placebo vibration or no
vibration
There is very low-quality evidence for vibratory stimulation that
does not allow us to draw firm conclusions. We did not find ev-
idence that vibratory devices reduce pain, though the results are
imprecise and may be compatible with no difference in pain or
an increase in pain or a decrease in pain. We did not find evi-
dence that vibratory stimulation leads to a significant difference in
analgesic use, although one study reported a reduced requirement
24 hours after appliance placement but not at other time points
(Miles 2016).
Chewing adjuncts (chewing gum or bite wafer) versus
no chewing gum or placebo
On the basis of very low-quality evidence, we found inconsistent
results relating to alleviation of self-reported pain associated with
the use of chewing adjuncts. We found insufficient evidence to
enable conclusions to be drawn relating to the secondary outcomes
of this review.
Psychosocial and other interventions
On the basis of one trial, we found very low-quality evidence
of decreased pain experience with brain wave music or cognitive
behavioural therapy, although effects were inconsistent. There was
no evidence relating to the secondary outcomes of this review.
The effectiveness of post-treatment text messaging was assessed in
one study assessed at high risk of bias, with a reduction in pain
experience observed at four of the seven time intervals assessed.
We assessed the quality of this evidence as very low.
Overall completeness and applicability of
evidence
We included and assessed patient-centred outcomes, including
levels of pain experience, requirement for rescue medications and
functional impacts of orthodontic treatment. Assessments were
primarily undertaken over the initial week following appliance
placement. More prolonged assessment was undertaken in three
of the included studies (Benson 2012; Lobre 2015; Woodhouse
2015). Pain, however, is known to arise throughout orthodontic
treatment, albeit typically being less severe after the initial period.
Harms associated with the alternatives to anti-inflammatories as-
sessed in the studies were not considered. While these harms are
likely to be minimal, given the conservative nature of the inter-
ventions, it is important that they are considered.
A 100 mm VAS was the most common pain assessment method
used in the included studies. Given the relatively low number of
included studies, it is important that outcomes assessed in future
clinical trials use similar outcome measures; the 100 mm VAS ap-
pears to be the most accepted approach at present. Notwithstand-
ing, a threshold level of pain reduction in terms of intensity or
duration has yet to be established.
There were insufficient data to consider the impact of different
participant characteristics on the effectiveness of the interventions
to reduce pain; for example, we could not investigate whether there
was a differential response between males and females.
The lack of evidence identified for interventions in this review
may reflect the relative infancy of a variety of the approaches to
address orthodontic pain and that use of analgesics is an estab-
lished practice. It is important that some of the more promis-
ing approaches are subjected to further prospective analysis with
prolonged follow-up and that the secondary outcomes including
potential harms of these novel interventions are assessed. Further
research should also address the cost implications of these inter-
ventions as they do represent additional procedures; for example,
using proprietary devices to facilitate delivery of vibratory stimu-
lation may have significant associated costs for clinicians, patients,
or both.
Quality of the evidence
Limitations in study design and implementation
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The design of the included studies was generally adequate; how-
ever, only one included study was assessed at low risk of bias. Re-
porting was generally poor; methods applied to conceal allocation,
and to blind investigators and participants were unclear in a num-
ber of studies (Figure 2). Blinding of participants was attempted in
a number of studies with the use of placebo interventions. Blind-
ing participants was not possible for some interventions, such as
use of altered chewing.
Indirectness of the evidence
The primary objective of this review - subjective assessment of
pain experience - was considered in all the included studies. How-
ever, there were very few studies for each of the intervention types
assessed, with some interventions only assessed in one study. Dif-
fering protocols and proprietary brands of interventions such as
LLLT or vibratory stimulation were used, making direct compar-
isons more difficult. Moreover, pain assessments were recorded
over the initial week following appliance placement or manipula-
tion in each study; extended follow-up was performed in only two
studies. Therefore, the relative effectiveness of non-pharmacologi-
cal interventions over the course of orthodontic treatment remains
unclear. Data relating to harms or other impacts of interventions
or compliance-based procedures were not reported in the included
studies. However, the research settings were representative; most
included studies were undertaken in either hospital or university
centres and involved both adolescent and adult participants.
Inconsistency of results
Assessment of the consistency of reported outcomes in the in-
cluded studies was challenging because of the small number of
included studies, variation among interventions, and insufficient
usable data being available. For example, studies that reported on
chewing adjuncts reported findings in opposite directions.
Imprecision of results
The quality of the evidence was downgraded for imprecision be-
cause of the lack of similar studies, low numbers of participants
and wide confidence intervals.
Publication bias
We undertook a detailed search for both published and unpub-
lished studies, with no restrictions on language to limit the risk
of publication bias. We searched the reference lists of included
studies and contacted many study authors to obtain information
that was not included in the published reports. Given that few
studies comparing similar interventions were found, funnel plot
assessment of publication bias was not possible (Higgins 2011).
Potential biases in the review process
Efforts were made to reduce bias in the review process by ensuring
a comprehensive search for potentially eligible studies. The inde-
pendent, duplicate assessments of study eligibility and data extrac-
tion, limited the likelihood of additional bias. We also chose broad
inclusion criteria, leading to a clinically heterogeneous group of
studies presenting a range of interventions. We made changes to
the review methods following publication of the protocol (see
Differences between protocol and review). We acknowledge that
post hoc changes to the review methods may have introduced a
risk of bias.
Agreements and disagreements with other
studies or reviews
No previous systematic review has assessed the impact of non-
pharmacological interventions to alleviate pain during orthodon-
tic treatment. Other systematic reviews have addressed the poten-
tial value of some of these interventions, such as adjunctive vibra-
tory stimulation on the rate of orthodontic tooth movement have
(El-Angbawi 2015).
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
There is a lack of reliable evidence concerning the effectiveness
of a range of non-pharmacological interventions to manage or-
thodontic pain. A small number of studies provided low-quality
evidence that orthodontic pain may be reduced in the short term
by use of low-level laser irradiation; however, further prospective
research considering pain experiences both during the initial stages
and throughout orthodontic treatment are required.
Implications for research
There is need for further comprehensive clinical trials that as-
sess the effectiveness of non-pharmacological interventions for or-
thodontic pain. Future trials should be robust, well-designed and
reported in accordance with the CONSORT statement or exten-
sions of the CONSORT statement. Clear methodological con-
duct and reporting would help with appraisal of study results, ac-
curate judgements about risk of bias, and the overall quality of the
evidence. Moreover, studies with unclear methodology have been
shown to produce biased estimates of treatment effects (Schulz
1995). Detailed reporting of methods, such as generation of al-
location concealment, and numbers and reasons for participants’
withdrawals and exclusions, is required. Where possible the use of
a placebo to enable blinding would also be helpful.
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Further research should evaluate emerging techniques in relation
to pain experienced throughout treatment. It is important that
these assessments also incorporate a holistic evaluation of both
the potential benefits and possible harms associated with these
interventions. Costs should be also be considered. Some of the
more novel techniques require prolonged daily use of an appliance
(such as vibratory stimulation), which has implications for cost,
compliance and impact on daily life.
A limitation of a number of the included studies was the short-
term nature of the assessment. Orthodontic treatment is lengthy
and pain is known to arise both after the initial visit and following
regular adjustment appointments. It would be helpful if future
studies evaluated pain experience over prolonged periods. If po-
tential benefits associated with clinician-delivered pain alleviation
procedures are proven, there may be potential value in repeating
these procedures throughout the course of treatment.
While most clinical trials used continuous scales as a means of
recording pain experience, it is accepted that many outcome mea-
sures used in clinical trials are not standardised patient-oriented
outcome measurements. A need remains for the development of
an accepted set of patient-oriented outcomes within many special-
ties, including orthodontics.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Benson 2012
Methods Trial design: RCT, 2 groups
Location: Charles Clifford Hospital, Sheffield, UK
Number of centres: 1
Participants SELECTION CRITERIA
• Aged up to 18 years
The following exclusion criteria were applied.
• Patients with a cleft of the lip or palate
• Patients with phenylketonuria (who must avoid products containing aspartame or
artificial sweeteners which contain phenylalanine)
• Significant medical history
• Poor dental or periodontal health precluding the use of fixed appliances
• Undergoing orthodontic treatment with fixed upper and lower appliances
Participants: 68
Number randomised: 68 (intervention: 37; control: 31)
Number evaluated: 57 (intervention: 29; control: 28) (31 male, 26 female)
Mean age: 14.7 (SD 1.5) years intervention group, 13.9 (SD 1.6) control group
Interventions INTERVENTION: Chewing gum (Wrigley’s Orbit Complete) for as-required use at
the bonding/separator appointment and subsequent appointments up to the visit after
the placement of the working arch wire (0.019 × 0.025 mm stainless steel)
CONTROL: Non-chewing gum group, specifically asked not to chew gum for the
duration of the study
Outcomes The primary outcome was the Total Impact Score (TIS) reported by the participants
at 24 hours and 1 week after placement of the brace. Secondary outcomes included
assessment of pain using the VAS measurements at 24 hours and 1 week and reported
use of oral analgesics
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “...using computer-generated random
numbers” (p. 180)
Allocation concealment (selection bias) Low risk “The allocations were concealed in consec-
utively numbered opaque sealed envelopes,
which were opened only after the patient
and parent had agreed to enter the trial and
had signed the consent form.” (p. 180)
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Benson 2012 (Continued)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Efforts to blind operators to group al-
location was undertaken where possible:
“Masking of the patient to group allocation
was not possible because they were either
asked to chew gum or not. Masking of the
operator was undertaken where practical;
however this was not always possible.” (p.
180)
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Blinding of chief assessors (participants)
“Masking of the operator was undertaken
where practical; however this was not al-
ways possible” (p. 180)
Incomplete outcome data (attrition bias)
All outcomes
Low risk 57 of 68 randomised participants were
analysed. Reasons for failure to complete
including drop-out, failure to complete di-
aries and an administrative error were out-
lined
Comment: Failure to complete was re-
ported with the reason given and these rep-
resented fewer than 20% of the sample
Selective reporting (reporting bias) Low risk Study protocol not available, but outcomes
mentioned in the methods section ap-
peared to have been reported
Other bias Low risk Appeared to be free of other forms of bias
Farzanegan 2012
Methods Trial design: RCT, 5 groups
Location: Dental School, Mashhad University of Medical Sciences, Iran
Number of centres: 1
Participants SELECTION CRITERIA
• Scheduled for fixed appliance treatment
• Moderate crowding (4 to 8 mm) according to Little’s irregularity index
• Requiring extraction of 4 first premolars for orthodontic reasons
•Extractions scheduled to be finished at least 2weeks before placement of the orthodontic
appliances
• No systemic diseases and not receiving analgesic therapy
• Undergoing orthodontic treatment with fixed upper and lower appliances
Participants: 50 (50 female)
Number randomised: 50 (Group 1: 10; Group 2: 10; Group 3: 10; Group 4: 10; Group
5: 10)
Number evaluated: not mentioned
Age range: 13 years to 18 years
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Farzanegan 2012 (Continued)
Interventions INTERVENTION:
1. Ibuprofen group, participants took a 400 mg ibuprofen tablet immediately after arch
wire placement and at 8-hourly intervals for 1 week if pain persisted
2. Chewing gum group, participants chewed a sugar-free gum (Orbit, The Wrigley
Company) for 5 minutes immediately after arch wire placement and at 8-hour intervals
for 1 week if they experienced pain
3. Soft-viscoelastic group, participants usedhorseshoe-shaped viscoelastic polyvinyl silox-
ane bite wafers with low toughness. Participants in these 2 groups chewed or bit down
on the bite wafers for 5 minutes at 8-hour intervals for 1 week if pain persisted
4. Hard-viscoelastic group, participants used horseshoe-shaped viscoelastic polyvinyl
siloxane bite wafers with moderate toughness. Participants in these 2 groups chewed or
bit down on the bite wafers for 5 minutes at 8-hour intervals for 1 week if pain persisted
CONTROL:
Placebo: Participants asked to take a B vitamin tablet immediately after arch wire
placement and at 8-hour intervals for 1 week if pain persisted
Outcomes Pain intensity (measured on a 100 mm VAS) after 2 hours, 6 hours and at bedtime
on the day of arch wire placement, and at 24 hours, 2 days, 3 days and 7 days after
first appointment. Severity of pain was recorded for 4 oral functions including chewing,
biting, fitting back teeth and fitting front teeth
Notes We compared intervention groups 2, 3 and 4 against control
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “...according to their clinic entrance num-
ber and a random number table” (p. 170)
. This was confirmed by e-mail communi-
cation (22 August 2015)
Allocation concealment (selection bias) Unclear risk Not mentioned in paper and clarification
not given in e-mail communication
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk A placebo was used but as it was a tablet, it
is uncertain if this was an effective placebo
for the three chewing intervention groups
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Participants in the control group received a
placebo intervention but this was not iden-
tical so it is uncertain if it was effective
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Drop-outs or numbers completing the
study were not mentioned
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Farzanegan 2012 (Continued)
Selective reporting (reporting bias) Low risk Study protocol not available, but outcomes
mentioned in the methods section ap-
peared to have been reported
Other bias Low risk Appeared to be free of other forms of bias
Harazaki 1997
Methods Trial design: RCT, 3 groups
Location: Department of Orthodontics, Tokyo Dental College, Japan
Number of centres: 1
Participants SELECTION CRITERIA
• Receiving edgewise orthodontic therapy
• Undergoing orthodontic treatment with fixed upper and lower appliances
Participants: 84 (27 male, 57 female)
Number randomised: 84 (Group 1: 44 ; Group 2: 20; Group 3: 20)
Number evaluated: 84 (Group 1: 44 ; Group 2: 20; Group 3: 20)
Age range: 11 years to 34 years
Interventions INTERVENTION: Either a laser irradiation group receiving laser therapy for 30 seconds
at the apical region of each tooth from a labial or lingual direction (Group 2)
or a blind irradiation group receiving the same therapy without irradiation (Group 3)
CONTROL: No irradiation (Group 1)|
Outcomes Questionnaire involving 5 questions exploring the timing at which the pain commenced,
when pain peaked and abated, and exploring the nature and severity of the discomfort
Notes We could not extract any usable data from this paper
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not mentioned
Allocation concealment (selection bias) Unclear risk Not mentioned
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk A blind irradiation placebo group was in-
cluded in the study
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Participants were blinded in groups 1 and
2
33Non-pharmacological interventions for alleviating pain during orthodontic treatment (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Harazaki 1997 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Low risk No drop-outs
Selective reporting (reporting bias) Low risk Study protocol not available, but outcomes
mentioned in the methods section ap-
peared to have been reported
Other bias Unclear risk Not enough detail provided to allow an as-
sessment
Huang 2016
Methods Trial design: RCT, 3 groups
Location: Orthodontic Department of the West China Hospital of Stomatology,
Chengdu, China
Number of centres: 1
Participants SELECTION CRITERIA
Recruited from among 54 right-handed healthy young medical college students after
they provided written informed consent.
(i) aged 22 ± 3 years; (ii) mild-to-moderate malocclusion and no previous orthodon-
tic treatment; (iii) no oral diseases which may lead to pain perception (i.e. toothache,
periodontitis, oral ulcer, pulpitis) within 1 week; (iv) no infectious diseases or systemic
diseases or both; (v) pain threshold from 3 to 60 seconds; and (vi) pain tolerance < 5
min, as reflected by the cold pressor test (CPT)
EXCLUSION CRITERIA
Psychiatric issues, abnormal pain perception, and excessive anxiety or depression based on
screening by the CPT with EEGmonitoring and a series of questionnaires, including the
Short-form McGill Pain Questionnaire, the Trait-Anxiety Inventory, the State-Anxiety
Inventory, and the Self-Rating Depression Scale
Participants: 36 (gender distribution not given)
Number randomised: 36 (cognitive behavioural therapy: 12; brain wave music: 12;
control: 12)
Number evaluated: 36 (cognitive behavioural therapy: 12; brain wave music: 12; control:
12)
Mean age: 22 ± 3 years
Interventions INTERVENTIONS: Cognitive behavior therapy or brain wave music both lasted for
approximately 3minutes. There was a verbal introduction (2minutes) before and a silent
period (5 minutes) after each intervention, the intervention therefore lasted 10 minutes
overall
CONTROL: No special instructions
Outcomes VAS scores recorded daily 1 to 10 days, then at 14 and 30 days after initial orthodontic
appliance placement
Notes
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Huang 2016 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “A stratified block randomisation was per-
formed before the treatment... One indi-
vidual in each block was randomly assigned
to the BWM group, the CBT group or the
control group, via a computer-generated se-
quence.” (p. 2)
Allocation concealment (selection bias) Low risk “Group allocation was performed by aChi-
nese Clinical Trial Registry statistician” (p.
2)
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Operators were blinded to group alloca-
tion. “One individual in each block was
randomly assigned to the BWM group,
the CBT group or the control group, via
a computer-generated sequence performed
by a Chinese Clinical Trial Registry statis-
tician. The clinicians and data analysts
were blinded to the allocation. Separately,
in isolated rooms, the three groups re-
ceived the same 15-min instruction regard-
ing orthodontic treatment, tooth-move-
ment pain, oral hygiene maintenance and
the respective study procedures.”
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Data analysts were blinded. As described in
blinding section above, trial authors con-
sidered participants to be blinded but it is
unclear if this would have been effective as
placebo was not used
Incomplete outcome data (attrition bias)
All outcomes
Low risk No losses
Selective reporting (reporting bias) Low risk Study protocol not available, but outcomes
mentioned in the methods section ap-
peared to have been reported
Other bias Low risk Appeared to be free of other forms of bias
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Keith 2013
Methods Trial design: RCT, 2 groups
Location: Seton Hill University, Pennsylvania, USA
Number of centres: 1
Participants SELECTION CRITERIA
• Undergoing orthodontic treatment with fixed upper and lower appliances
• Aged 10 years to 18 years
• Access to a cellular telephone
• No previous orthodontic treatment
• No reported chronic usage of analgesic medications
• No pain-related pathology or disease
Participants: 39 (14 male, 25 female)
Number randomised: 39 (intervention: 20; control: 19)
Number evaluated: 39 (intervention: 20; control: 19)
Mean age: 12.6 years intervention group, 14.2 years control group
Interventions INTERVENTION: Text message following appointment offering encouragement and
concern
CONTROL: No text message
Outcomes Outcomes: Pain intensity was measured on a 100 mm VAS; the use of analgesia at
baseline, 4 hours following appliance placement and at the same time daily for 7 days
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “CONSORT 2010 and randomised se-
quencing guidelines, subject group assign-
ment was done” (p. 606)
Allocation concealment (selection bias) High risk “...assigned to the experimental and con-
trol groups in an attempt to closely approx-
imate the trial arms based on a minimiza-
tion protocol as described by Pandis” (p.
606)
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Blinding of researchers was not mentioned:
“Subjects were blinded as to group status
and were not made aware that a text mes-
sage was part of the study.” (p. 606). It is
uncertain this would have been an effective
method of blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Trial authors considered participants (out-
come assessors for pain) to be blinded as
they were not aware that a text message
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Keith 2013 (Continued)
was part of the study; however, it is uncer-
tain that this would have been an effective
method of blinding
Incomplete outcome data (attrition bias)
All outcomes
Low risk No drop-outs
Selective reporting (reporting bias) Low risk Study protocol not available, but outcomes
mentioned in the methods section ap-
peared to have been reported
Other bias Low risk Appeared to be free of other forms of bias
Kim 2013
Methods Trial design: RCT, 3 groups
Location: Catholic University of Korea, South Korea
Number of centres: 1
Participants SELECTION CRITERIA
• Complete eruption of the second molars
• No open interproximal contacts of the first molar
• No previous orthodontic treatment, metabolic and periodontal diseases
• Not on medication
• Undergoing orthodontic treatment with fixed upper and lower appliances
Participants: 88 (23 male, 65 female)
Number randomised: 88 (Group 1: 28; Group 2: 30; Group 3: 30)
Number evaluated: 88 (Group 1: 28; Group 2: 30; Group 3: 30)
Mean age: 22.7 years
Interventions INTERVENTION: Participants in the (1) laser irradiation group (N = 28) were asked to
use the laser for 30 seconds on each area immediately then every 12 hours for 1 week with
close contact between the tip and mucosa to irradiate the mesiobuccal, mesiolingual,
distobuccal, and distolingual areas of the molars. The laser was a low-level medical
semiconductor laser device with an AlGaInP diode, wave length of 635 nM, energy of
10 m mJ, field diameter of 5.6 mm, and output potency of 6 mW
CONTROL: LED was a placebo applied using the same regime as the intervention
group. The LED device had a wave length of 635 NM and output of 12.9 mW of the
same exterior design (Group 2)
Another control group received no irradiation or placebo (Group 3)
Outcomes Pain intensity (measured on a 100 mm VAS) at 11 intervals: 5 minutes, 1 hour, 6 hours,
12 hours and then at days 1, 2, 3, 4, 5, 6 and 7 after separator placement
Notes
Risk of bias
37Non-pharmacological interventions for alleviating pain during orthodontic treatment (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Kim 2013 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “Subjects were randomly assigned” (p. 612)
Allocation concealment (selection bias) Unclear risk Not mentioned
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk “Subjects assigned to the laser and LED
groups were blinded to their assignment.”
(p. 612)
Blinding of the investigators was not men-
tioned but a placebo LED device was used
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Participants were blinded
Incomplete outcome data (attrition bias)
All outcomes
Low risk No drop-outs
Selective reporting (reporting bias) Low risk Study protocol not available, but outcomes
mentioned in the methods section ap-
peared to have been reported
Other bias Low risk Appeared to be free of other forms of bias
Lobre 2015
Methods Trial design: RCT, 2 groups
Location: Tri-service orthodontic program, Texas, USA
Number of centres: 1
Participants SELECTION CRITERIA
•Healthy child (aged 10 years and over) and adult patients offering consent and approved
for comprehensive orthodontic treatment
• Participants were excluded from recruitment if they currently had any pre-existing pain
conditions or if they were unable to comply with the restriction on using any analgesic
drugs during the course of the study
Participants: 70
Number randomised: 70 (intervention: 35; control: 35)
Number evaluated: 58 (intervention: 29; control: 29)
Baseline characteristics: not reported, although authors state (p. 627): “Stratified analysis
was used for gender and age; however, the study was not powered adequately to look at
subgroup differences.”
Interventions INTERVENTION: AcceleDent Aura micropulse vibration device. Participants assigned
to the experimental groupwere instructed touse the device for 20minutes daily beginning
on the day separators were placed and continuing daily for the first 4 months of levelling
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Lobre 2015 (Continued)
and aligning
CONTROL: No intervention to alleviate pain
Outcomes Pain intensity measured on a VAS
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Participants were assigned to comparison
groups using a block allocation sequence.
This sequence was concealed from the in-
vestigators. Participants were randomised
in blocks of 10 with five patients being allo-
cated to each arm of the trial until all 70 pa-
tients were randomised. For participant al-
location, a computer- generated list of ran-
dom numbers was used. The randomiza-
tion sequence was created using Stata 9.0
statistical software (StataCorp, College Sta-
tion, Tex) with a 1:1 allocation using a ran-
dom block size of 10.” (p. 2)
Allocation concealment (selection bias) Low risk “This sequence was concealed from the in-
vestigators... A designated individual (not
part of the investigative team) performed
the allocation.” (p. 2)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Blinding of participants was not under-
taken
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Blinding of participants was not under-
taken
Incomplete outcome data (attrition bias)
All outcomes
Low risk “In each group, 29of 35participants (83%)
remained in the study after the 4-month
trial. Six patients from each group were
excluded from the study. Four of six pa-
tients from the device groups used a quan-
tity of rescue medication that was consid-
ered excessive, mostly for non dental pain.
The other two patients were noncompliant
with their pain diary. In the control group,
three patients used rescue medication too
often (headache, body pain) and three oth-
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Lobre 2015 (Continued)
ers were noncompliant with respect to the
pain diary.” (p. 2)
Comment: Failure to complete was re-
ported with the reason given and these rep-
resented fewer than 20% of the sample
Selective reporting (reporting bias) Low risk Study protocol not available, but outcomes
mentioned in the methods section ap-
peared to have been reported
Other bias Unclear risk Baseline characteristics were not given; im-
balances between the groups were possible
Marie 2003
Methods Trial design: RCT, 2 groups
Location: Louisiana State University, Louisiana, USA
Number of centres: 1
Participants SELECTION CRITERIA
Inclusion criteria
• No previous pain
• Undergoing orthodontic treatment with fixed upper and lower appliances
Exclusion criteria
• None reported
Participants: 48 (21 male, 27 female)
Number randomised: 48 (intervention: 24; control: 24)
Number evaluated: not mentioned
Mean age: 25.3 years (SD not reported) in control group, 25.2 years (SD not reported)
in intervention group
Interventions INTERVENTION: vibratory stimulation for 15 minutes after wire placement
CONTROL: no intervention to alleviate pain
Outcomes Pain intensity measured on a VAS
Notes No usable data provided
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “Randomly divided” (p. 206)
Allocation concealment (selection bias) High risk Concealment of allocation was not under-
taken
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Marie 2003 (Continued)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Blinding of participants was not under-
taken
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Blinding of participants was not under-
taken
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Drop-outs or numbers completing the
study were not mentioned
Selective reporting (reporting bias) Low risk Study protocol not available, but outcomes
mentioned in the methods section ap-
peared to have been reported
Other bias Unclear risk Inadequate description of baseline charac-
teristics of the sample and little informa-
tion on the nature of the intervention
Miles 2012
Methods Trial design: RCT, 2 groups
Location: Private practice, Caloundra, Australia
Number of centres: 1
Participants SELECTION CRITERIA
Inclusion criteria
• Aged 11 years to 15 years
• Non-extraction in the mandibular arch
• No impactions or unerupted teeth
• Fixed appliance from 6 to 6 in both arches
• Residencing locally
• Undergoing orthodontic treatment with fixed upper and lower appliances
Exclusion criteria
• None reported
Participants: 66 (26 males, 40 females)
Number randomised: 66 (intervention: 33; control: 33)
Number evaluated: 60 (intervention: 30; control: 28)
Mean age: 13.1 years (SD 0.2) in control group, 13 years (SD 0.2) in intervention group
Interventions INTERVENTION: vibratory stimulation (Tooth Masseuse) for 20 minutes daily
CONTROL: no intervention to alleviate pain
Outcomes Discomfort intensity measured on a 100 mm VAS at 5 time points: immediately after
placement, 6 to 8 hours, 1, 3 and 7 days later
Notes
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Miles 2012 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “...randomly assigned in blocks of six to en-
sure even numbers in the control and ex-
perimental groups” (p. 214)
Allocation concealment (selection bias) Unclear risk Not mentioned
Blinding of participants and personnel
(performance bias)
All outcomes
High risk “The clinician was blinded to the study
participants at all appointments.” (p. 216)
However, the participants were not blinded
to group allocation
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Participants (the outcome assessors for
pain) were not blinded
Incomplete outcome data (attrition bias)
All outcomes
Low risk 58 of 66 randomised participants were
analysed. Reasons for failure to complete
and time points at which drop-outs oc-
curred were given
Comment: Failure to complete was re-
ported with the reason given and these rep-
resented fewer than 20% of the sample
Selective reporting (reporting bias) Low risk Study protocol not available, but outcomes
mentioned in the methods section ap-
peared to have been reported
Other bias Low risk Appeared to be free of other forms of bias
Miles 2016
Methods Trial design: RCT, 2 groups
Location: Private practice, Caloundra, Australia
Number of centres: 1
Participants SELECTION CRITERIA
Eligibility for inclusion consisted of (1) children aged up to 16 years, (2) a fully erupted
dentition fromfirst molar forward, (3) erupted or erupting secondmolars, (4) nomissing
or previously extracted permanent teeth, (5) undergoing comprehensive orthodontic
treatment with full fixed appliances, and (6) a Class II malocclusion requiring extraction
of 2 maxillary premolars but no mandibular extractions
Number randomised: 40 (20 males, 20 females)
Number evaluated: 40 (intervention: 20; control: 20)
Mean age: 12.7 (SD 1.2) years intervention group, 13.0 (SD 1.5) control group
42Non-pharmacological interventions for alleviating pain during orthodontic treatment (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Miles 2016 (Continued)
Sex: 14 female/6 male intervention group, 12 female/8 male control group
Interventions INTERVENTION: AcceleDent Aura appliance for 20 minutes per day
CONTROL: no vibration appliance
All patients were indirectly bonded with conventional 0.018-in slot, MBT prescription
brackets (Victory Series; 3M Unitek, Monrovia, CA, USA) on all mandibular teeth and
the maxillary premolars and molars, whereas the maxillary incisors and canines were
bonded with MBT equivalent prescription self-ligating In-Ovation C ceramic brackets
(GAC International, Bohemia, NY, USA). The arch wires were identical in both groups
during the 10-week experimental period: a 0.014-in thermal nickel-titanium wire (G&
HWire, Franklin, IN. USA)
Outcomes The primary outcome was the change in mandibular anterior arch perimeter over the
10 weeks of the trial. Secondary outcomes were the change in the mandibular arch
irregularity index over the 10 weeks and amounts of discomfort and analgesic use during
the first week of the trial
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Randomization was performed using per-
muted blocks of 10 randomly generated
numbers with the randomgeneration func-
tion in Excel (Microsoft, Redmond, WA,
USA);...” (p. 929)
Allocation concealment (selection bias) Low risk “...the numbers were sealed in opaque en-
velopes and shuffled by a staff member. A
clinical assistant opened an envelope for the
group assignment after a patient’s brackets
were bonded and gave routine instructions
in a closed consultation room to ensure that
the operator (P.M.) was blinded” (p. 929)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk “Patients were aware of their treatment
group...
The operator was blinded to the group as-
signment” (p. 929)
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Participants were not blinded (see above)
Incomplete outcome data (attrition bias)
All outcomes
Low risk No losses
43Non-pharmacological interventions for alleviating pain during orthodontic treatment (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Miles 2016 (Continued)
Selective reporting (reporting bias) Low risk Study protocol not available, but outcomes
mentioned in the methods section ap-
peared to have been reported
Other bias Low risk Appeared to be free of other forms of bias
Nobrega 2013
Methods Trial design: RCT, 2 groups
Location: orthodontic clinic, São José dos Campos, Brazil
Number of centres: 1
Participants SELECTION CRITERIA
Inclusion criteria
• Aged over 12 years
• Presence of erupted permanent first and second lower molars
• Presence of erupted first and second premolars
• Voluntary participation in the study confirmed by signing the informed consent form
Exclusion criteria
• Using antibiotics or analgesics
• Being pregnant or breastfeeding
• Cardiac disease
• Systemic diseases
• Contraindications to NSAID use
• Having undergone any type of surgical procedure during the preceding 2 weeks
• Gastrointestinal illness (gastritis, gastric ulcer, lactose intolerance, chronic diarrhoea or
intestinal inflammatory illness)
• Presence of melanin pigmentation in the gingiva in the area to be irradiated
• Presence of treated or untreated apical bone lesions
• Presence of one or more diastema in the region of the molars or premolars, or both
Participants: 60 (22 males, 38 females)
Number randomised: 60 (intervention: 30; control: 30)
Number evaluated: 60 (intervention: 30; control: 30)
Mean age: 17.9 (SD 3.9) years intervention group, 17.1 (SD 3.9) years control group
Interventions INTERVENTION: immediately after placement of separators, irradiation with low-
level laser therapy (LLLT) using an AlGaAs diode (with a single spot application to the
region of the root apex at a dose of 2 J/cm², and along the root axis buccally with three
spot applications of 1 J/cm² at the infrared wave length of 830 nM)
CONTROL: placebo irradiation with infrared light radiation in the same locations
taking the same amount of time for the procedure as was used for the intervention group
Outcomes Pain intensity on a VAS. The primary outcome was mean pain intensity in intervention
and control groups at 5 time points: 2, 6 and 24 hours, and 3 and 5 days after separator
placement. The secondary outcome was frequency of absence of pain in intervention
and control groups
Notes
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Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “The procedures were codified as A and
B, and for allocation of the partici-
pants, a computer generated list of ran-
dom letter was used (programme avail-
able at: http/www.dave-reed.com/Nifty/
randSeq.html) with blocked randomiza-
tion to ensure the ratio 1:1.” (p. 12)
Allocation concealment (selection bias) Low risk “The randomization sequence was pro-
tected in opaque envelopes, sealed, and
consecutively numbered, and the entire
procedure was performed by another per-
son, and not the investigator.” (p.12)
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk “During the phase of procedures and
data collection, only the manufacturer had
knowledge of the respective functions of
the laser probes and not only the pa-
tients, but also the operator/researcher were
blinded, and in all the cases, the researcher
also acted as the operator.” (p.12)
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk “During the phase of procedures and
data collection, only the manufacturer had
knowledge of the respective functions of
the laser probes and not only the pa-
tients, but also the operator/researcher were
blinded, and in all the cases, the researcher
also acted as the operator.” (p.12)
Incomplete outcome data (attrition bias)
All outcomes
Low risk No drop-outs
Selective reporting (reporting bias) Low risk Study protocol mentioned (http://ecgovbr.
bvsalud.org/, registration number RBR-
8v3tkq) but inaccessible. Outcomes men-
tioned in the methods section appeared to
have been reported
Other bias Low risk Appeared to be free of other forms of bias
45Non-pharmacological interventions for alleviating pain during orthodontic treatment (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Otasevic 2006
Methods Trial design: RCT, 2 groups
Location: Royal London Hospital, UK
Number of centres: 1
Participants SELECTION CRITERIA
Inclusion criteria
• Aged up to 16 years
• Undergoing orthodontic treatment with fixed upper and lower appliance
Exclusion criteria
• None reported
Participants: 125
Number randomised: 125. No further details given
Number evaluated: 84 (intervention: 38; control: 46). These included 47 females and
37 males, with 21 and 26 females in the intervention and control groups, respectively
Mean age: 14 (SD 1.7) years intervention group, 14.1 (SD 1.7) years control group
Interventions INTERVENTION: A wafer was chewed under supervision for 10 minutes immediately
after placement of the fixed appliance. Additional wafers were given to the patients to
take home. These were to be chewed if they experienced pain
CONTROL: Participants were instructed not to chew for 3 hours following placement
of the appliance and to avoid chewing hard foods for the next 7 days
Outcomes Pain intensity on a 100 mm VAS each morning, lunch time and evening for 7 days
Notes Only figures with medians without variance or precision were provided
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “randomly allocated” (p. e10)
Allocation concealment (selection bias) High risk Allocation concealment was not under-
taken
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Blinding of participants was not under-
taken
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Blinding of participants was not under-
taken
Incomplete outcome data (attrition bias)
All outcomes
High risk 84 of 125 randomised participants were
analysed. Comment: Failure to complete
was at a high level, 33% of the sample, with
no explanation
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Selective reporting (reporting bias) Low risk Study protocol not available, but outcomes
mentioned in the methods section ap-
peared to have been reported
Other bias Low risk Appeared to be free of other forms of bias
Turhani 2006
Methods Trial design: RCT, 2 groups
Location: Medical University of Vienna, Austria
Number of centres: 1
Participants SELECTION CRITERIA
Inclusion criteria
• None reported
• Undergoing orthodontic treatment with fixed upper and lower appliances
Exclusion criteria
• Chronic pain
• History of neurological and psychiatric disorders
Participants: 76 (30 males, 46 females)
Number randomised: 76 (intervention: 38; control: 38)
Number evaluated: 76 (intervention: 38; control: 38)
Mean age: 25.1 years intervention group, 21 years control group (SD not reported for
either group)
Interventions INTERVENTION: Immediately after placement of one arch wire, irradiation with low-
level laser therapy (LLLT) using a dental version of Mini Laser 2075 (Helbo Photody-
namic Systems GmbH & Co KG, Linz, Austria; 670 nM, 75 mW)
CONTROL: Placebo laser therapywithout active irradiation (participants were blinded)
Outcomes Prevalence (item 1), quality (item 2), intensity (items 3 and 4), localisation (item 3), and
the time course (item 4) of subjectively perceived pain. Items 3 and 4 were evaluated
with a 5-point scale (0, no pain; 5, unbearable pain). Measured at 6, 30 and 54 hours
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk P. 371: “...randomly selected and received
placebo laser treatment” (p. 371)
Allocation concealment (selection bias) Unclear risk Not mentioned
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk “The operator who applied the laser treat-
ment and the placebo could distinguish be-
tween them, but the patients were blinded
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to the difference” (p. 372)
On page 375, authors state the knowledge
of the operator may have been subcon-
sciously transferred to the participants
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk “The operator who applied the laser treat-
ment and the placebo could distinguish be-
tween them, but the patients were blinded
to the difference” (p. 372)
On page 375, authors state the knowledge
of the operator may have been subcon-
sciously transferred to the participants
Incomplete outcome data (attrition bias)
All outcomes
Low risk No drop-outs
Selective reporting (reporting bias) Low risk Study protocol not available, but outcomes
mentioned in the methods section ap-
peared to have been reported
Other bias Low risk Appeared to be free of other forms of bias
Woodhouse 2015
Methods Trial design: RCT, 3 groups
Location: King’s College London Dental Institute (Guy’s Hospital); Royal Alexander
Children’s Hospital, Brighton and William Harvey Hospital, Ashford; UK
Number of centres: 3
Participants SELECTION CRITERIA
Inclusion criteria
• Aged up to 20 years at treatment start
• No medical contra-indications, including regular medication
• In permanent dentition
• Mandibular arch incisor irregularity
• Extraction of mandibular first premolars as part of the orthodontic treatment plan
• Undergoing orthodontic treatment with fixed upper and lower appliances
Exclusion criteria
• None reported
Participants: 81 (40 males, 41 females)
Number randomised: 81 (Group 1: 29; Group 2: 25; Group 3: 27)
Number evaluated at visit 1: 80 (Group 1: 29; Group 2: 25; Group 3: 26)
Number evaluated at visit 2: 77 (Group 1: 28; Group 2: 24; Group 3: 25)
Mean age: 14.1 (SD 1.7) years
Interventions INTERVENTION: Pre-adjusted edgewise fixed-appliance treatment with adjunctive
daily use of a functional AcceleDent (OrthoAccel Technologies, Inc,Houston, TX,USA)
vibrational device (Group 1)
CONTROL: Pre-adjusted edgewise fixed-appliance treatment with adjunctive use of a
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non-functional (sham) AcceleDent device (Group 2) and pre-adjusted edgewise fixed-
appliance treatment alone (Group 3)
Participants allocated to both the working and sham devices were instructed to use the
device for 20 minutes daily
The bonding method and fixed appliance was standardised between groups (3MVictory
series, 3M Unitek, Monrovia, CA, USA) with a pre-determined sequence used in each
group during the period of study. Arch wires were inserted and ligated from first molar to
first molar using conventional elastomerics. Arch wire progression occurred only if full
bracket engagement was achievable, which required the relevant arch wire to be fully tied
into the base of the bracket slot adjacent to each tie wing using elastomeric ligation. No
bite planes, auxiliary arches, inter-maxillary elastics, headgears or temporary anchorage
devices were used during the period of investigation
Outcomes Pain intensity on a VAS. The primary outcome measure was maximum pain experience
during initial alignment. Secondary outcomes were mean pain at each time point (4
hours, 24 hours, 3 days and 7 days) after placement of the brace and the first arch wire
adjustment; alignment rate; and oral analgesic consumption during the study period
Notes Used Group 1 vs Group 2 in analysis
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “...sequence was generated by one in-
vestigator (MTC) using GraphPad on-
line software (http://www.graphpad.com/
quickcalcs/index.cfm) with unrestricted
equal participant allocation (1:1:1)” (p. 3)
Allocation concealment (selection bias) Low risk Central allocation was used: “...undertaken
centrally at King’s College London, in-
dependently from the clinical operators,
following recruitment (allocation conceal-
ment)” (p. 3)
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Page 3: ’Treating clinicians and subjects
could not be blinded to the use of Accele-
Dent; however, subjects were blinded to the
allocationof functional or shamappliances,
as both were identical in appearance (with
the exception that the sham appliance did
not vibrate).’
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk “Treating clinicians and subjects could not
be blinded to the use of AcceleDent; how-
ever, subjects were blinded to the allocation
of functional or sham appliances, as both
were identical in appearance (with the ex-
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ception that the sham appliance did not vi-
brate).” (p. 3)
“The pain questionnaires and extracted
data were coded appropriately, so that both
outcome assessor (NRW) and statistician
(SNP) were blinded to subject allocation.
The coding of the data was broken after the
end of the analysis and no breach of blind-
ing was identified.” (p. 3)
Incomplete outcome data (attrition bias)
All outcomes
Low risk 80 of 81 randomised participants were
analysed at the first time point and 77 at the
second. Reasons for failure to complete and
the time point at which drop-outs occurred
were given and these represented fewer than
20% of the sample
Selective reporting (reporting bias) Low risk Prespecified outcomes and those men-
tioned in the methods section appeared to
have been reported
Other bias Low risk Appeared to be free of other forms of bias
RCT = randomised controlled trial
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Abtahi 2013 Split-mouth study
Artés-Ribas 2013 Split-mouth study
Bartlett 2005 Non-randomised study
Bicacki 2012 Split-mouth study
Domínguez 2013 Split-mouth study
Doshi-Mehta 2012 Split-mouth study
Eslamian 2014 Split-mouth study
Esper 2011 Non-randomised study
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Gasperini 2014 Assessed effects of low-level laser on swelling and pain related to orthognathic surgery rather than orthodontics
Lim 1995 Split-mouth study
Marini 2013 Split-mouth study
Murdock 2010 Used positive control group involving analgesic use
Roth 1986 Four-factor repeated measures design
Characteristics of studies awaiting assessment [ordered by study ID]
Tortamano 2009
Methods Trial design: RCT, 6 groups
Location: University of São Paulo, Brazil
Number of centres: 1
Participants SELECTION CRITERIA
Inclusion criteria
• Enrolled at the orthodontic clinic at the School of Dentistry of the University of São Paulo, Brazil
• About to start orthodontic treatment with the MBT straight-wire technique
• Signed informed consent agreeing to the research procedures
•Undergoing orthodontic treatment with fixed upper and lower appliances
Exclusion criteria
• None reported
Participants: 60 (18 males, 42 females)
Number randomised: 60 (Group 1: 10; Group 2: 10; Group 3: 10; Group 4: 10; Group 5: 10; Group 6: 10)
Number evaluated: 60 (Group 1: 10; Group 2: 10; Group 3: 10; Group 4: 10; Group 5: 10; Group 6: 10)
Mean age: 15.9 (SD not reported) years, range 12 to 18 years
Interventions INTERVENTION: Immediately after placement of 1 arch wire, irradiation with low-level laser therapy (LLLT)
using an AlGaAs diode was done with a fixed appliance in place in the maxilla (Group 1) or mandible (Group 2)
CONTROL: Placebo irradiation groups had a laser probe positioned into the mouth overlying the root and could
hear a sound every 10 seconds in the maxilla (Group 3) or mandible (Group 4)
In the ’no intervention’ groups irradiation was not simulated but a fixed appliance was in place in the maxilla (Group
5) or mandible (Group 6)
Outcomes Pain intensity on a 10-point numerical scale over a 7-day period
Notes No usable data. Scale not given. Survey was completed for a week but no breakdown by day. Unclear how the
intervention was applied and whether one patient received in the same or different interventions in two jaws
E-mail 30 October 2015:
”Dear Dr Santos,
We are conducting aCochrane systematic reviewonnon-pharmacologicalmethods for pain reduction in orthodontics.
Your trial is eligible for inclusion:
Low-level laser therapy for pain caused by placement of the first orthodontic arch wire: A randomised clinical trial
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Tortamano et al AJODO 2009;136:662-7
I was wondering if it would be possible to provide some details that would allow me to include your study in the
meta-analysis. Ideally, I would like to have individual patient data as it is unclear from the methods and Table II if
the patients received the same intervention in both jaws. If patients received the same intervention in both jaws I can
get average values per group per patient by averaging the values for maxilla and mandible from Table II. However,
if patient received different intervention I would be grateful if you could provide individual patient data so I can
somehow account for the existing within patient correlations, which I cannot extract now from the reported values.
Your help will be greatly appreciated.
Many thanks,
Nick
52Non-pharmacological interventions for alleviating pain during orthodontic treatment (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
D A T A A N D A N A L Y S E S
Comparison 1. Low-level laser therapy versus placebo
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Patient-reported pain intensity
or pain relief measured on a
visual analogue scale (VAS) at 6
hours, 24 hours, 3 days, 7 days
2 Mean Difference (IV, Random, 95% CI) Subtotals only
1.1 6 hours 2 118 Mean Difference (IV, Random, 95% CI) -10.63 [-22.33, 1.
07]
1.2 24 hours 2 118 Mean Difference (IV, Random, 95% CI) -20.27 [-24.50, -16.
04]
1.3 3 days 2 118 Mean Difference (IV, Random, 95% CI) -10.76 [-13.80, -7.
73]
1.4 7 days 1 58 Mean Difference (IV, Random, 95% CI) -6.39 [-8.65, -4.13]
Comparison 2. Vibratory stimulation versus placebo or no vibration
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Patient-reported pain intensity
or pain relief measured on a
visual analogue scale (VAS) at 6
hours, 24 hours, 3 days and 7
days
3 Mean Difference (IV, Random, 95% CI) Subtotals only
1.1 6 hours 2 114 Mean Difference (IV, Random, 95% CI) -0.52 [-9.41, 8.36]
1.2 24 hours 3 154 Mean Difference (IV, Random, 95% CI) 1.32 [-11.79, 14.43]
1.3 3 days 3 152 Mean Difference (IV, Random, 95% CI) 1.82 [-5.12, 8.76]
1.4 7 days 3 152 Mean Difference (IV, Random, 95% CI) 1.28 [-3.16, 5.71]
2 Patient-reported pain intensity
or pain relief measured on a
visual analogue scale (VAS) at 1
month, 2 months, 3 months
and 4 months.
1 Mean Difference (IV, Random, 95% CI) Subtotals only
2.1 1 month 1 58 Mean Difference (IV, Random, 95% CI) -8.42 [-19.46, 2.62]
2.2 2 months 1 58 Mean Difference (IV, Random, 95% CI) -8.49 [-16.54, -0.44]
2.3 3 months 1 58 Mean Difference (IV, Random, 95% CI) -5.39 [-11.14, 0.36]
2.4 4 months 1 58 Mean Difference (IV, Random, 95% CI) -6.26 [-11.85, -0.67]
3 Patient-reported pain intensity
or pain relief measured on a
visual analogue scale (VAS)
after insertion of 0.018 NiTi
wire
1 Mean Difference (IV, Random, 95% CI) Subtotals only
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3.1 6 hours 1 52 Mean Difference (IV, Random, 95% CI) 9.21 [-6.79, 25.21]
3.2 1 day 1 52 Mean Difference (IV, Random, 95% CI) 18.22 [2.09, 34.35]
3.3 3 days 1 52 Mean Difference (IV, Random, 95% CI) 5.55 [-6.50, 17.60]
3.4 7 days 1 52 Mean Difference (IV, Random, 95% CI) 9.26 [-2.07, 20.59]
4 Rescue medication 2 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
4.1 After bonding 1 40 Risk Ratio (M-H, Fixed, 95% CI) 1.0 [0.43, 2.33]
4.2 1 day 1 40 Risk Ratio (M-H, Fixed, 95% CI) 0.63 [0.44, 0.92]
4.3 3 days 1 40 Risk Ratio (M-H, Fixed, 95% CI) 0.75 [0.19, 2.93]
4.4 7 days 1 14 Risk Ratio (M-H, Fixed, 95% CI) 0.33 [0.02, 7.02]
4.5 After insertion of 0.014
NiTi wire
1 55 Risk Ratio (M-H, Fixed, 95% CI) 0.99 [0.72, 1.37]
4.6 After insertion of 0.018
NiTi wire
1 53 Risk Ratio (M-H, Fixed, 95% CI) 1.00 [0.46, 2.20]
Comparison 3. Chewing gum or wafer versus placebo or no gum
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Patient-reported pain intensity
or pain relief measured on
chewing on a visual analogue
scale (VAS) at 6 hours, 24
hours, 3 days and 7 days
2 Mean Difference (IV, Random, 95% CI) Subtotals only
1.1 6 hours 1 39 Mean Difference (IV, Random, 95% CI) -1.39 [-3.42, 0.64]
1.2 24 hours 2 96 Mean Difference (IV, Random, 95% CI) -15.38 [-28.90, -1.
86]
1.3 3 days 1 39 Mean Difference (IV, Random, 95% CI) -29.16 [-51.67, -6.
65]
1.4 7 days 2 96 Mean Difference (IV, Random, 95% CI) -15.17 [-32.44, 2.
11]
2 Quality of life or patient
satisfaction
1 Risk Ratio (M-H, Random, 95% CI) Subtotals only
2.1 24 hours 1 57 Risk Ratio (M-H, Random, 95% CI) 0.45 [0.22, 0.94]
2.2 7 days 1 57 Risk Ratio (M-H, Random, 95% CI) 0.68 [0.30, 1.53]
Comparison 4. Brainwave therapy or cognitive behavioural therapy versus control
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Patient-reported pain intensity
or pain relief measured on a
visual analogue scale (VAS),
numerical rating scale (NRS)
or any categorical scale: VAS
1 Mean Difference (IV, Random, 95% CI) Subtotals only
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1.1 BWM vs. control: 24
hours
1 24 Mean Difference (IV, Random, 95% CI) -26.65 [-39.06, -14.
24]
1.2 BWM vs. control: 3 days 1 24 Mean Difference (IV, Random, 95% CI) -23.44 [-36.82, -10.
06]
1.3 BWM vs. control: 7 days 1 24 Mean Difference (IV, Random, 95% CI) -4.72 [-15.83, 6.39]
1.4 CBT vs. control: 24 hours 1 24 Mean Difference (IV, Random, 95% CI) -20.67 [-32.12, -9.
22]
1.5 CBT vs. control: 3 days 1 24 Mean Difference (IV, Random, 95% CI) -27.91 [-40.10, -15.
72]
1.6 CBT vs. control: 7 days 1 24 Mean Difference (IV, Random, 95% CI) -6.5 [-17.64, 4.64]
Comparison 5. Post-treatment text message versus no text message
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Patient-reported pain intensity -
VAS 0 to 100 mm
1 Mean Difference (IV, Random, 95% CI) Subtotals only
1.1 4 hours 1 39 Mean Difference (IV, Random, 95% CI) 0.88 [-14.30, 16.06]
1.2 3 days 1 39 Mean Difference (IV, Random, 95% CI) -15.84 [-30.95, -0.
73]
1.3 7 days 1 39 Mean Difference (IV, Random, 95% CI) -0.13 [-6.07, 5.81]
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Analysis 1.1. Comparison 1 Low-level laser therapy versus placebo, Outcome 1 Patient-reported pain
intensity or pain relief measured on a visual analogue scale (VAS) at 6 hours, 24 hours, 3 days, 7 days.
Review: Non-pharmacological interventions for alleviating pain during orthodontic treatment
Comparison: 1 Low-level laser therapy versus placebo
Outcome: 1 Patient-reported pain intensity or pain relief measured on a visual analogue scale (VAS) at 6 hours, 24 hours, 3 days, 7 days
Study or subgroup
Low-level
laser
therapy Placebo
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 6 hours
Nobrega 2013 30 3.4 (11) 30 21.3 (28.4) 40.3 % -17.90 [ -28.80, -7.00 ]
Kim 2013 28 19.59 (5.53) 30 25.32 (5.33) 59.7 % -5.73 [ -8.53, -2.93 ]
Subtotal (95% CI) 58 60 100.0 % -10.63 [ -22.33, 1.07 ]
Heterogeneity: Tau2 = 57.58; Chi2 = 4.49, df = 1 (P = 0.03); I2 =78%
Test for overall effect: Z = 1.78 (P = 0.075)
2 24 hours
Nobrega 2013 30 9.1 (14.1) 30 36 (34.4) 9.6 % -26.90 [ -40.20, -13.60 ]
Kim 2013 28 26.64 (6.28) 30 46.21 (6.05) 90.4 % -19.57 [ -22.75, -16.39 ]
Subtotal (95% CI) 58 60 100.0 % -20.27 [ -24.50, -16.04 ]
Heterogeneity: Tau2 = 2.51; Chi2 = 1.10, df = 1 (P = 0.29); I2 =9%
Test for overall effect: Z = 9.40 (P < 0.00001)
3 3 days
Nobrega 2013 30 4.9 (10.6) 30 21 (30.9) 6.7 % -16.10 [ -27.79, -4.41 ]
Kim 2013 28 26.4 (6.2) 30 36.78 (5.98) 93.3 % -10.38 [ -13.52, -7.24 ]
Subtotal (95% CI) 58 60 100.0 % -10.76 [ -13.80, -7.73 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.86, df = 1 (P = 0.35); I2 =0.0%
Test for overall effect: Z = 6.96 (P < 0.00001)
4 7 days
Kim 2013 28 9.55 (4.47) 30 15.94 (4.31) 100.0 % -6.39 [ -8.65, -4.13 ]
Subtotal (95% CI) 28 30 100.0 % -6.39 [ -8.65, -4.13 ]
Heterogeneity: not applicable
Test for overall effect: Z = 5.53 (P < 0.00001)
-100 -50 0 50 100
Low level laser therapy Placebo or No irradiation
56Non-pharmacological interventions for alleviating pain during orthodontic treatment (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 2.1. Comparison 2 Vibratory stimulation versus placebo or no vibration, Outcome 1 Patient-
reported pain intensity or pain relief measured on a visual analogue scale (VAS) at 6 hours, 24 hours, 3 days
and 7 days.
Review: Non-pharmacological interventions for alleviating pain during orthodontic treatment
Comparison: 2 Vibratory stimulation versus placebo or no vibration
Outcome: 1 Patient-reported pain intensity or pain relief measured on a visual analogue scale (VAS) at 6 hours, 24 hours, 3 days and 7 days
Study or subgroup Vibratory stimulation
Placebo or
no vibration
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 6 hours
Miles 2012 30 40.4 (20.8) 30 39.6 (25.8) 56.2 % 0.80 [ -11.06, 12.66 ]
Woodhouse 2015 29 46.34 (24.65) 25 48.56 (25.46) 43.8 % -2.22 [ -15.64, 11.20 ]
Subtotal (95% CI) 59 55 100.0 % -0.52 [ -9.41, 8.36 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.11, df = 1 (P = 0.74); I2 =0.0%
Test for overall effect: Z = 0.12 (P = 0.91)
2 24 hours
Miles 2012 30 41.5 (27.2) 30 47.6 (24.5) 36.3 % -6.10 [ -19.20, 7.00 ]
Miles 2016 20 47.44 (32.21) 20 51.92 (21.51) 29.1 % -4.48 [ -21.45, 12.49 ]
Woodhouse 2015 29 59.1 (22.39) 25 45.12 (28.89) 34.6 % 13.98 [ 0.03, 27.93 ]
Subtotal (95% CI) 79 75 100.0 % 1.32 [ -11.79, 14.43 ]
Heterogeneity: Tau2 = 78.57; Chi2 = 4.84, df = 2 (P = 0.09); I2 =59%
Test for overall effect: Z = 0.20 (P = 0.84)
3 3 days
Miles 2012 30 18.8 (18.5) 28 19.9 (15.5) 54.5 % -1.10 [ -9.86, 7.66 ]
Miles 2016 20 27.04 (22.41) 20 27.28 (22.4) 23.6 % -0.24 [ -14.13, 13.65 ]
Woodhouse 2015 29 40.14 (29.5) 25 28.88 (24.54) 22.0 % 11.26 [ -3.16, 25.68 ]
Subtotal (95% CI) 79 73 100.0 % 1.82 [ -5.12, 8.76 ]
Heterogeneity: Tau2 = 3.02; Chi2 = 2.16, df = 2 (P = 0.34); I2 =7%
Test for overall effect: Z = 0.51 (P = 0.61)
4 7 days
Miles 2012 30 4 (6.3) 28 5.5 (7.8) 52.7 % -1.50 [ -5.16, 2.16 ]
Miles 2016 20 8.334 (11.85) 20 4.71 (5.783) 34.3 % 3.63 [ -2.15, 9.40 ]
Woodhouse 2015 29 22.03 (23.24) 25 15.68 (19.14) 12.9 % 6.35 [ -4.96, 17.66 ]
Subtotal (95% CI) 79 73 100.0 % 1.28 [ -3.16, 5.71 ]
Heterogeneity: Tau2 = 6.20; Chi2 = 3.29, df = 2 (P = 0.19); I2 =39%
Test for overall effect: Z = 0.56 (P = 0.57)
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Analysis 2.2. Comparison 2 Vibratory stimulation versus placebo or no vibration, Outcome 2 Patient-
reported pain intensity or pain relief measured on a visual analogue scale (VAS) at 1 month, 2 months, 3
months and 4 months..
Review: Non-pharmacological interventions for alleviating pain during orthodontic treatment
Comparison: 2 Vibratory stimulation versus placebo or no vibration
Outcome: 2 Patient-reported pain intensity or pain relief measured on a visual analogue scale (VAS) at 1 month, 2 months, 3 months and 4 months.
Study or subgroup Vibratory stimulation Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 1 month
Lobre 2015 29 8.78 (21.451) 29 17.2 (21.451) 100.0 % -8.42 [ -19.46, 2.62 ]
Subtotal (95% CI) 29 29 100.0 % -8.42 [ -19.46, 2.62 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.49 (P = 0.13)
2 2 months
Lobre 2015 29 4.62 (15.644) 29 13.11 (15.644) 100.0 % -8.49 [ -16.54, -0.44 ]
Subtotal (95% CI) 29 29 100.0 % -8.49 [ -16.54, -0.44 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.07 (P = 0.039)
3 3 months
Lobre 2015 29 3.83 (11.178) 29 9.22 (11.1779) 100.0 % -5.39 [ -11.14, 0.36 ]
Subtotal (95% CI) 29 29 100.0 % -5.39 [ -11.14, 0.36 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.84 (P = 0.066)
4 4 months
Lobre 2015 29 2.54 (10.864) 29 8.8 (10.8638) 100.0 % -6.26 [ -11.85, -0.67 ]
Subtotal (95% CI) 29 29 100.0 % -6.26 [ -11.85, -0.67 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.19 (P = 0.028)
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Analysis 2.3. Comparison 2 Vibratory stimulation versus placebo or no vibration, Outcome 3 Patient-
reported pain intensity or pain relief measured on a visual analogue scale (VAS) after insertion of 0.018 NiTi
wire.
Review: Non-pharmacological interventions for alleviating pain during orthodontic treatment
Comparison: 2 Vibratory stimulation versus placebo or no vibration
Outcome: 3 Patient-reported pain intensity or pain relief measured on a visual analogue scale (VAS) after insertion of 0.018 NiTi wire
Study or subgroup Vibratory stimulation Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 6 hours
Woodhouse 2015 28 47.21 (30.52) 24 38 (28.31) 100.0 % 9.21 [ -6.79, 25.21 ]
Subtotal (95% CI) 28 24 100.0 % 9.21 [ -6.79, 25.21 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.13 (P = 0.26)
2 1 day
Woodhouse 2015 28 53.18 (31.18) 24 34.96 (28.13) 100.0 % 18.22 [ 2.09, 34.35 ]
Subtotal (95% CI) 28 24 100.0 % 18.22 [ 2.09, 34.35 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.21 (P = 0.027)
3 3 days
Woodhouse 2015 28 27.43 (23.44) 24 21.88 (20.9) 100.0 % 5.55 [ -6.50, 17.60 ]
Subtotal (95% CI) 28 24 100.0 % 5.55 [ -6.50, 17.60 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.90 (P = 0.37)
4 7 days
Woodhouse 2015 28 18.43 (28.88) 24 9.17 (9.33) 100.0 % 9.26 [ -2.07, 20.59 ]
Subtotal (95% CI) 28 24 100.0 % 9.26 [ -2.07, 20.59 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.60 (P = 0.11)
Test for subgroup differences: Chi2 = 1.54, df = 3 (P = 0.67), I2 =0.0%
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Analysis 2.4. Comparison 2 Vibratory stimulation versus placebo or no vibration, Outcome 4 Rescue
medication.
Review: Non-pharmacological interventions for alleviating pain during orthodontic treatment
Comparison: 2 Vibratory stimulation versus placebo or no vibration
Outcome: 4 Rescue medication
Study or subgroup Vibratory stimulation Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 After bonding
Miles 2016 7/20 7/20 100.0 % 1.00 [ 0.43, 2.33 ]
Subtotal (95% CI) 20 20 100.0 % 1.00 [ 0.43, 2.33 ]
Total events: 7 (Vibratory stimulation), 7 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P = 1.0)
2 1 day
Miles 2016 12/20 19/20 100.0 % 0.63 [ 0.44, 0.92 ]
Subtotal (95% CI) 20 20 100.0 % 0.63 [ 0.44, 0.92 ]
Total events: 12 (Vibratory stimulation), 19 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 2.42 (P = 0.015)
3 3 days
Miles 2016 3/20 4/20 100.0 % 0.75 [ 0.19, 2.93 ]
Subtotal (95% CI) 20 20 100.0 % 0.75 [ 0.19, 2.93 ]
Total events: 3 (Vibratory stimulation), 4 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.41 (P = 0.68)
4 7 days
Miles 2016 0/7 1/7 100.0 % 0.33 [ 0.02, 7.02 ]
Subtotal (95% CI) 7 7 100.0 % 0.33 [ 0.02, 7.02 ]
Total events: 0 (Vibratory stimulation), 1 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.71 (P = 0.48)
5 After insertion of 0.014 NiTi wire
Woodhouse 2015 21/29 19/26 100.0 % 0.99 [ 0.72, 1.37 ]
Subtotal (95% CI) 29 26 100.0 % 0.99 [ 0.72, 1.37 ]
Total events: 21 (Vibratory stimulation), 19 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.06 (P = 0.96)
6 After insertion of 0.018 NiTi wire
Woodhouse 2015 9/28 8/25 100.0 % 1.00 [ 0.46, 2.20 ]
Subtotal (95% CI) 28 25 100.0 % 1.00 [ 0.46, 2.20 ]
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(. . . Continued)
Study or subgroup Vibratory stimulation Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Total events: 9 (Vibratory stimulation), 8 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.01 (P = 0.99)
Test for subgroup differences: Chi2 = 4.00, df = 5 (P = 0.55), I2 =0.0%
0.01 0.1 1 10 100
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Analysis 3.1. Comparison 3 Chewing gum or wafer versus placebo or no gum, Outcome 1 Patient-reported
pain intensity or pain relief measured on chewing on a visual analogue scale (VAS) at 6 hours, 24 hours, 3 days
and 7 days.
Review: Non-pharmacological interventions for alleviating pain during orthodontic treatment
Comparison: 3 Chewing gum or wafer versus placebo or no gum
Outcome: 1 Patient-reported pain intensity or pain relief measured on chewing on a visual analogue scale (VAS) at 6 hours, 24 hours, 3 days and 7 days
Study or subgroup Chewing gum
No chewing
gum or
placebo
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 6 hours
Farzanegan 2012 10 5.7 (3.75) 3 6.45 (2.58) 29.6 % -0.75 [ -4.48, 2.98 ]
Farzanegan 2012 10 4.4 (2.51) 3 6.45 (2.58) 37.7 % -2.05 [ -5.36, 1.26 ]
Farzanegan 2012 10 5.25 (3.28) 3 6.45 (2.58) 32.6 % -1.20 [ -4.76, 2.36 ]
Subtotal (95% CI) 30 9 100.0 % -1.39 [ -3.42, 0.64 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.28, df = 2 (P = 0.87); I2 =0.0%
Test for overall effect: Z = 1.34 (P = 0.18)
2 24 hours
Benson 2012 29 31.6 (22.6) 28 41.6 (25.6) 62.7 % -10.00 [ -22.55, 2.55 ]
Farzanegan 2012 10 34.7 (38.3) 3 74.7 (27.3) 11.1 % -40.00 [ -78.96, -1.04 ]
Farzanegan 2012 10 42.2 (28.3) 3 74.7 (27.3) 13.1 % -32.50 [ -68.02, 3.02 ]
Farzanegan 2012 10 71.5 (28.3) 3 74.7 (27.3) 13.1 % -3.20 [ -38.72, 32.32 ]
Subtotal (95% CI) 59 37 100.0 % -15.38 [ -28.90, -1.86 ]
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(. . . Continued)
Study or subgroup Chewing gum
No chewing
gum or
placebo
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Heterogeneity: Tau2 = 34.83; Chi2 = 3.50, df = 3 (P = 0.32); I2 =14%
Test for overall effect: Z = 2.23 (P = 0.026)
3 3 days
Farzanegan 2012 10 3.15 (37.5) 3 50.4 (30.7) 29.0 % -47.25 [ -89.05, -5.45 ]
Farzanegan 2012 10 25 (29) 3 50.4 (30.7) 33.1 % -25.40 [ -64.51, 13.71 ]
Farzanegan 2012 10 31.8 (18.4) 3 50.4 (30.7) 37.9 % -18.60 [ -55.16, 17.96 ]
Subtotal (95% CI) 30 9 100.0 % -29.16 [ -51.67, -6.65 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 1.08, df = 2 (P = 0.58); I2 =0.0%
Test for overall effect: Z = 2.54 (P = 0.011)
4 7 days
Benson 2012 29 21.4 (21.6) 28 22.6 (16.2) 46.2 % -1.20 [ -11.09, 8.69 ]
Farzanegan 2012 10 12.2 (21.1) 3 40.2 (27.7) 17.5 % -28.00 [ -61.96, 5.96 ]
Farzanegan 2012 10 11.4 (17.5) 3 40.2 (27.7) 18.1 % -28.80 [ -61.97, 4.37 ]
Farzanegan 2012 10 15.5 (17.2) 3 40.2 (27.7) 18.2 % -24.70 [ -57.81, 8.41 ]
Subtotal (95% CI) 59 37 100.0 % -15.17 [ -32.44, 2.11 ]
Heterogeneity: Tau2 = 142.77; Chi2 = 5.54, df = 3 (P = 0.14); I2 =46%
Test for overall effect: Z = 1.72 (P = 0.085)
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Analysis 3.2. Comparison 3 Chewing gum or wafer versus placebo or no gum, Outcome 2 Quality of life or
patient satisfaction.
Review: Non-pharmacological interventions for alleviating pain during orthodontic treatment
Comparison: 3 Chewing gum or wafer versus placebo or no gum
Outcome: 2 Quality of life or patient satisfaction
Study or subgroup Chewing gum No chewing gum Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 24 hours
Benson 2012 7/29 15/28 100.0 % 0.45 [ 0.22, 0.94 ]
Subtotal (95% CI) 29 28 100.0 % 0.45 [ 0.22, 0.94 ]
Total events: 7 (Chewing gum), 15 (No chewing gum)
Heterogeneity: not applicable
Test for overall effect: Z = 2.14 (P = 0.033)
2 7 days
Benson 2012 7/29 10/28 100.0 % 0.68 [ 0.30, 1.53 ]
Subtotal (95% CI) 29 28 100.0 % 0.68 [ 0.30, 1.53 ]
Total events: 7 (Chewing gum), 10 (No chewing gum)
Heterogeneity: not applicable
Test for overall effect: Z = 0.94 (P = 0.35)
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Analysis 4.1. Comparison 4 Brainwave therapy or cognitive behavioural therapy versus control, Outcome 1
Patient-reported pain intensity or pain relief measured on a visual analogue scale (VAS), numerical rating scale
(NRS) or any categorical scale: VAS.
Review: Non-pharmacological interventions for alleviating pain during orthodontic treatment
Comparison: 4 Brainwave therapy or cognitive behavioural therapy versus control
Outcome: 1 Patient-reported pain intensity or pain relief measured on a visual analogue scale (VAS), numerical rating scale (NRS) or any categorical scale: VAS
Study or subgroup BWM or CBT
No special
instructions
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 BWM vs. control: 24 hours
Huang 2016 12 27.18 (16.99) 12 53.83 (13.86) 100.0 % -26.65 [ -39.06, -14.24 ]
Subtotal (95% CI) 12 12 100.0 % -26.65 [ -39.06, -14.24 ]
Heterogeneity: not applicable
Test for overall effect: Z = 4.21 (P = 0.000025)
2 BWM vs. control: 3 days
Huang 2016 12 19.72 (14.45) 12 43.16 (18.71) 100.0 % -23.44 [ -36.82, -10.06 ]
Subtotal (95% CI) 12 12 100.0 % -23.44 [ -36.82, -10.06 ]
Heterogeneity: not applicable
Test for overall effect: Z = 3.43 (P = 0.00059)
3 BWM vs. control: 7 days
Huang 2016 12 6.36 (4.63) 12 11.08 (19.09) 100.0 % -4.72 [ -15.83, 6.39 ]
Subtotal (95% CI) 12 12 100.0 % -4.72 [ -15.83, 6.39 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.83 (P = 0.41)
4 CBT vs. control: 24 hours
Huang 2016 12 33.16 (14.74) 12 53.83 (13.86) 100.0 % -20.67 [ -32.12, -9.22 ]
Subtotal (95% CI) 12 12 100.0 % -20.67 [ -32.12, -9.22 ]
Heterogeneity: not applicable
Test for overall effect: Z = 3.54 (P = 0.00040)
5 CBT vs. control: 3 days
Huang 2016 12 15.25 (10.67) 12 43.16 (18.71) 100.0 % -27.91 [ -40.10, -15.72 ]
Subtotal (95% CI) 12 12 100.0 % -27.91 [ -40.10, -15.72 ]
Heterogeneity: not applicable
Test for overall effect: Z = 4.49 (P < 0.00001)
6 CBT vs. control: 7 days
Huang 2016 12 4.58 (4.85) 12 11.08 (19.09) 100.0 % -6.50 [ -17.64, 4.64 ]
Subtotal (95% CI) 12 12 100.0 % -6.50 [ -17.64, 4.64 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.14 (P = 0.25)
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Analysis 5.1. Comparison 5 Post-treatment text message versus no text message, Outcome 1 Patient-
reported pain intensity - VAS 0 to 100 mm.
Review: Non-pharmacological interventions for alleviating pain during orthodontic treatment
Comparison: 5 Post-treatment text message versus no text message
Outcome: 1 Patient-reported pain intensity - VAS 0 to 100 mm
Study or subgroup Experimental Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 4 hours
Keith 2013 20 42.3 (24.155) 19 41.42 (24.204) 100.0 % 0.88 [ -14.30, 16.06 ]
Subtotal (95% CI) 20 19 100.0 % 0.88 [ -14.30, 16.06 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.11 (P = 0.91)
2 3 days
Keith 2013 20 33.05 (19.75) 19 48.89 (27.55) 100.0 % -15.84 [ -30.95, -0.73 ]
Subtotal (95% CI) 20 19 100.0 % -15.84 [ -30.95, -0.73 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.05 (P = 0.040)
3 7 days
Keith 2013 20 6.55 (8.864) 19 6.68 (9.995) 100.0 % -0.13 [ -6.07, 5.81 ]
Subtotal (95% CI) 20 19 100.0 % -0.13 [ -6.07, 5.81 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.04 (P = 0.97)
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A P P E N D I C E S
Appendix 1. Cochrane Oral Health’s Trials Register search strategy
#1 (orthodontic*) AND (INREGISTER)
#2 (((tooth or teeth or dental or oral*) AND (bracket* or brace* or wire* or headgear* or “head gear*” or facemask* or “face mask*” or
face-mask* or head-gear* or chincap* or facebow* or “chin cap*” or chin-cap* or “face bow*” or face-bow*))) AND (INREGISTER)
#3 (((tooth or teeth or dental or oral*) AND (appliance* or device*))) AND (INREGISTER)
#4 (((intraoral or “intra oral” or intra-oral or extraoral or “extra oral” or extra-oral) and (appliance* or device*) and (tooth or teeth or
dental))) AND (INREGISTER)
#5 (“activator appliance*”) AND (INREGISTER)
#6 (#1 or #2 or #3 or #4 or #5) AND (INREGISTER)
#7 (laser*) AND (INREGISTER)
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#8 ((vibrat* or acceledent)) AND (INREGISTER)
#9 ((“transcutaneous electric nerve stimulation” or TENS or electrostimulat* or electro-stimulat* or “electro stimulat*”)) AND (IN-
REGISTER)
#10 ((electroanalgesia or “percutaneous electric nerve stimulat*” or “percutaneous electrical nerve stimulat*”)) AND (INREGISTER)
#11 ((telemedicine or teledentistry or phone or telephone or call* or communicat*)) AND (INREGISTER)
#12 ((“bite wafer*” or “therapy wafer*” or “Elastobite wafer*” or “flex* wafer*” or “masticatory wafer*” or thera-bite*)) AND (INREG-
ISTER)
#13 (gum*) AND (INREGISTER)
#14 ((ice* or cryotherap* or “cold therap*”)) AND (INREGISTER)
#15 (acupunc*) AND (INREGISTER)
#16 (#7 or #8 or #9 or #10 or #11 or #12 or #13 or #14 or #15) AND (INREGISTER)
#17 (#6 and #16) AND (INREGISTER)
#18 ((pain* or analgesi* or discomfort* or ache* or tender* or sore* or odontalg*)) AND (INREGISTER)
#19 (#17 and #18) AND (INREGISTER)
Appendix 2. Cochrane Central Register of Controlled Clinical Trials (CENTRAL) search strategy
#1 MeSH descriptor: [Orthodontics] explode all trees
#2 orthodontic*
#3 ((tooth or teeth or dental or oral*) and (bracket* or brace* or wire* or headgear* or “head gear*” or facemask* or “face mask*” or
face-mask* or
head-gear* or chincap* or facebow* or “chin cap*” or chin-cap* or “face bow*” or face-bow*))
#4 ((tooth or teeth or dental or oral*) and (appliance* or device*))
#5 (“activator appliance*”)
#6 ((intraoral or “intra oral” or intra-oral or extraoral or “extra oral” or extra-oral) near/5 (appliance* or device*) and (tooth or teeth
or dental))
#7 #1 or #2 or #3 or #4 or #5 or #6
#8 MeSH descriptor: [Lasers] this term only
#9 laser*
#10 MeSH descriptor: [Vibration] this term only
#11 ((vibrat* near/5 stimulat*) or (mechanic* near/5 vibrat*) or acceledent)
#12 MeSH descriptor: [Transcutaneous Electric Nerve Stimulation] this term only
#13 TENS:ti,ab,kw
#14 (electrostimulat* or electro-stimulat* or “electro stimulat*”)
#15 (electroanalgesia or “percutaneous electric nerve stimulat*” or “percutaneous electrical nerve stimulat*”)
#16 MeSH descriptor: [Telemedicine] this term only
#17 (telemedicine or teledentistry or phone or telephone or call* or communicat*)
#18 ((bite near/5 wafer*) or (therapy near/5 wafer*) or “Elastobite wafer*” or (flex* near/5 wafer*) or (masticatory near/5 wafer*) or
thera-bite*)
#19 MeSH descriptor: [Chewing Gum] this term only
#20 gum*
#21 MeSH descriptor: [Ice] this term only
#22 ice*
#23 MeSH descriptor: [Cryotherapy] this term only
#24 (cryotherap* or “cold therap*”)
#25 MeSH descriptor: [Acupuncture] explode all trees
#26 acupuncture*
#27 #8 or #9 or #10 or #11 or #12 or #13 or #14 or #15 or #16 or #17 or #18 or #19 or #20 or #21 or #22 or #23 or #24 or #25 or #
26
#28 #7 and #27
#29 MeSH descriptor: [Pain] explode all trees
#30 (pain* or analgesi* or discomfort* or ache* or tender* or sore* or odontalg*)
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#31 #29 or #30
#32 #28 and #31
Appendix 3. MEDLINE Ovid search strategy
1. exp Orthodontics/
2. orthodontic$.mp.
3. ((tooth or teeth or dental$ or oral$) and (bracket$ or brace$ or wire$ or headgear$ or “head gear$” or facemask$ or “face mask$”
or head-gear$ or face-mask$ or chincap$ or facebow$ or “chin cap$” or chin-cap$ or face-bow$ or “face bow$”)).mp.
4. ((tooth or teeth or dental or oral) and ((function$ adj5 applianc$) or (fix$ adj5 applianc$) or (remov$ adj5 applianc$) or (function$
adj5 device$) or (fix$ adj5 device$) or (remov$ adj5 applianc$))).mp.
5. “activator appliance$”.mp.
6. (((intraoral or “intra oral” or intra-oral or extraoral or “extra oral” or extra-oral) adj5 (applianc$ or devic$)) and (tooth or teeth or
dental)).mp.
7. or/1-6
8. Lasers/
9. laser$.mp.
10. Vibration/
11. ((vibrat$ adj5 stimulat$) or (mechanic$ adj5 vibrat$) or acceledent).mp.
12. Transcutaneous Electric Nerve Stimulation/
13. TENS.mp.
14. (electrostimulat$ or electro-stimulat$ or “electro stimulat$” or “electric nerve stimulat$” or “electrical nerve stimulat$”).mp.
15. (electroanalgesia or “percutaneous electric nerve stimulat$” or “percutaneous electrical nerve stimulat$”).mp.
16. Telemedicine/
17. (telemedicine or teledentistry or phone or telephone or call$ or communicat$).mp.
18. ((bite$ adj5 wafer$) or (therapy adj5 wafer$) or “Elastobite wafer$” or (flex$ adj5 wafer$) or (masticatory adj5 wafer$) or Thera-
bite$).mp.
19. or/8-18
20. 7 and 19
21. Pain/
22. (pain$ or analgesi$ or discomfort$ or ache$ or tender$ or sore$ or odontalg$).mp.
23. 21 or 22
24. 20 and 23
Appendix 4. Embase Ovid search strategy
1. exp Orthodontics/
2. orthodontic$.mp.
3. ((tooth or teeth or dental$ or oral$) and (bracket$ or brace$ or wire$ or headgear$ or “head gear$” or facemask$ or “face mask$”
or head-gear$ or face-mask$ or chincap$ or facebow$ or “chin cap$” or chin-cap$ or face-bow$ or “face bow$”)).mp.
4. ((tooth or teeth or dental or oral) and ((function$ adj5 applianc$) or (fix$ adj5 applianc$) or (remov$ adj5 applianc$) or (function$
adj5 device$) or (fix$ adj5 device$) or (remov$ adj5 applianc$))).mp.
5. “activator appliance$”.mp.
6. (((intraoral or “intra oral” or intra-oral or extraoral or “extra oral” or extra-oral) adj5 (applianc$ or devic$)) and (tooth or teeth or
dental)).mp.
7. or/1-6
8. Lasers/
9. laser$.mp.
10. Vibration/
11. ((vibrat$ adj5 stimulat$) or (mechanic$ adj5 vibrat$) or acceledent).mp.
12. Transcutaneous Electric Nerve Stimulation/
13. TENS.mp.
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14. (electrostimulat$ or electro-stimulat$ or “electro stimulat$” or “electric nerve stimulat$” or “electrical nerve stimulat$”).mp.
15. (electroanalgesia or “percutaneous electric nerve stimulat$” or “percutaneous electrical nerve stimulat$”).mp.
16. Telemedicine/
17. (telemedicine or teledentistry or phone or telephone or call$ or communicat$).mp.
18. ((bite$ adj5 wafer$) or (therapy adj5 wafer$) or “Elastobite wafer$” or (flex$ adj5 wafer$) or (masticatory adj5 wafer$) or Thera-
bite$).mp.
19. or/8-18
20. 7 and 19
21. Pain/
22. (pain$ or analgesi$ or discomfort$ or ache$ or tender$ or sore$ or odontalg$).mp.
23. 21 or 22
24. 20 and 23
This subject search was linked to an adapted version of the Cochrane Embase Project filter for identifying RCTs in Embase Ovid (see
http://www.cochranelibrary.com/help/central-creation-details.html for information):
1. Randomized controlled trial/
2. Controlled clinical study/
3. Random$.ti,ab.
4. randomization/
5. intermethod comparison/
6. placebo.ti,ab.
7. (compare or compared or comparison).ti.
8. ((evaluated or evaluate or evaluating or assessed or assess) and (compare or compared or comparing or comparison)).ab.
9. (open adj label).ti,ab.
10. ((double or single or doubly or singly) adj (blind or blinded or blindly)).ti,ab.
11. double blind procedure/
12. parallel group$1.ti,ab.
13. (crossover or cross over).ti,ab.
14. ((assign$ or match or matched or allocation) adj5 (alternate or group$1 or intervention$1 or patient$1 or subject$1 or partici-
pant$1)).ti,ab.
15. (assigned or allocated).ti,ab.
16. (controlled adj7 (study or design or trial)).ti,ab.
17. (volunteer or volunteers).ti,ab.
18. trial.ti.
19. or/1-18
20. (exp animal/ or animal.hw. or nonhuman/) not (exp human/ or human cell/ or (human or humans).ti.)
21. 19 not 20
Appendix 5. EThOS search strategy
orthodontic AND pain
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Appendix 6. US National Institutes of Health Ongoing Trials Register (ClinicalTrials.gov) and World
Health Organization International Clinical Trials Registry Platform search strategy
ClinicalTrials.gov: orthodontic AND pain
WHO International Clinical Trials Registry Platform: orthodontic pain
C O N T R I B U T I O N S O F A U T H O R S
Draft the protocol: Hardus Strydom, Piotr Fudalej
Obtain copies of trials: Hardus Strydom, Padhraig Fleming
Selection of trials: Padhraig Fleming, Hardus Strydom, Piotr Fudalej, Nikolaos Pandis
Data extraction: Piotr Fudalej, Padhraig Fleming, Nikolaos Pandis
Enter data into RevMan: Nikolaos Pandis
Carry out analysis: Nikolaos Pandis
Interpret the analysis: Padhraig Fleming, Hardus Strydom, Piotr Fudalej, Nikolaos Pandis, Laura MacDonald, Christos Katsaros,
Michele Curatolo
Draft the final review: Padhraig Fleming, Laura MacDonald
Update the review: Padhraig Fleming, Nikolaos Pandis, Laura MacDonald
D E C L A R A T I O N S O F I N T E R E S T
Padhraig S Fleming: none known
Nikolaos Pandis: none known
Hardus Strydom: none known
Christos Katsaros: none known
Laura MacDonald: none known
Michele Curatolo: none known
Piotr Fudalej: none known
S O U R C E S O F S U P P O R T
Internal sources
• No sources of support supplied
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External sources
• Cochrane Oral Health Global Alliance, UK.
Through our Global Alliance (ohg.cochrane.org/partnerships-alliances), Cochrane Oral Health has received support from: British
Association for the Study of Community Dentistry, UK; British Association of Oral Surgeons, UK; British Orthodontic Society, UK;
British Society of Paediatric Dentistry, UK; British Society of Periodontology, UK; Canadian Dental Hygienists Association, Canada;
Centre for Dental Education & Research (CDER), India; Mayo Clinic, USA; National Center for Dental Hygiene Research &
Practice, USA; New York University College of Dentistry, USA; NHS Education for Scotland (NES), UK; and Royal College of
Surgeons of Edinburgh, UK
• National Institute for Health Research (NIHR), UK.
This project was supported by the NIHR, via Cochrane Infrastructure funding to Cochrane Oral Health. The views and opinions
expressed therein are those of the authors and do not necessarily reflect those of the Systematic Reviews Programme, NIHR, NHS or
the Department of Health
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
• We edited some wording in the Background and Methods sections.
• We included interventions delivered either before or after the onset of orthodontic pain as non-pharmacological approaches are
commonly prescribed prior to the onset of pain.
• We incorporated a number of different novel non-pharmacological interventions that had not been described at the protocol
stage.
• We updated the grey literature searches and the text in the Methods in relation to the ’Risk of bias’ assessment and ’Assessment
of reporting bias’ in line with the current version of the Cochrane Handbook for Systematic Reviews of Interventions, and we added more
details about the process.
• We modified the list of data extraction items.
• We had planned to dichotomise pain results, but because most studies measured pain on a visual analogue scale, we decided to
use the continuous data so not to lose information.
• We used risk ratio (RR) rather than odds ratio (OR) for binary data, in line with current Cochrane Oral Health policy, to
facilitate interpretation of the results.
• We used the random-effects model even if there were fewer than three studies because we considered this to be more appropriate
than the fixed-effect model.
• We added the outcomes reported in the ’Summary of findings tables’ to the Methods section.
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